https://biolegacyresearch.com/stock-plummets-as-genocea-axes-40-of-jobs-shifts-rd-focus-in-restructuring/ 2017-09-26T00:00:00+00:00 https://biolegacyresearch.com/irvine-scientific-increases-production-capacity-of-dry-powder-media-for-cell-culture/ 2017-09-26T00:00:00+00:00 https://biolegacyresearch.com/this-4-billion-asian-drugmaker-with-u-s-ops-just-went-on-the-market/ 2017-09-26T00:00:00+00:00 https://biolegacyresearch.com/2017-global-cesi-ms-symposium-hosted-by-sciex-to-be-held-in-boston/ 2017-09-26T00:00:00+00:00 https://biolegacyresearch.com/26-employee-cue-biopharma-seeks-40-million-ipo-eight-months-after-emerging-from-stealth-mode/ 2017-09-26T00:00:00+00:00 https://biolegacyresearch.com/bdynamk-capitalb-announces-first-closing-and-launch-of-life-sciences-venture-fund/ 2017-09-26T00:00:00+00:00 https://biolegacyresearch.com/biotech-startup-autolus-closes-80-million-for-novel-cancer-program/ 2017-09-26T00:00:00+00:00 https://biolegacyresearch.com/fda-goal-to-bring-puerto-rican-drug-manufacturing-back-online-gottlieb-says/ 2017-09-26T20:59:04+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-on-drugdevice-combination-product-classifications/ 2017-09-26T21:00:06+00:00 https://biolegacyresearch.com/emas-exodus-from-london-could-hit-staff-hard-internal-survey-shows/ 2017-09-26T21:01:11+00:00 https://biolegacyresearch.com/judge-dismisses-price-fixing-claims-against-generic-drugmakers/ 2017-09-26T21:03:45+00:00 https://biolegacyresearch.com/magellan-health-drugmaking-outlet-dinged-by-fda/ 2017-09-26T21:05:55+00:00 https://biolegacyresearch.com/something-in-the-water-at-dr-reddys-fda-says/ 2017-09-26T21:06:42+00:00 https://biolegacyresearch.com/ascendis-announces-pricing-of-public-offering-of-adss/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/two-biotech-startups-with-a-shot-at-reaching-a-billion-dollar-valuation/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/cardiofocus-announces-european-ce-mark-approval-of-the-next-generation-heartlight-excalibur-balloon-designed-for-the-treatment-of-atrial-fibrillation/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/former-top-biotech-analyst-charged-with-insider-trading/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/bnexusb-names-bdr-michelle-k-murrayb-chief-clinical-officer/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/big-pharma-edgy-after-revival-of-gileads-whistleblower-lawsuit/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/providence-medical-technology-expands-offering-of-posterior-cervical-fusion-solutions/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-facing-big-fda-decisions-in-october/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/badc-biob-to-invest-11-million-on-bioconjugation-facility/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/bmaxwell-biosciencesb-ceo-faces-backlash-after-openly-discriminating-against-men/ 2017-09-27T00:00:00+00:00 https://biolegacyresearch.com/phrma-to-support-limiting-acute-pain-opioid-prescriptions-to-seven-day-supplies/ 2017-09-27T20:40:03+00:00 https://biolegacyresearch.com/fda-publishes-list-of-products-compounded-by-outsourcing-facilities/ 2017-09-27T20:41:03+00:00 https://biolegacyresearch.com/ptab-invalidates-aventis-patent-following-mylan-challenge/ 2017-09-27T20:42:37+00:00 https://biolegacyresearch.com/judge-allows-most-of-wash-citys-case-against-purdue-to-continue/ 2017-09-27T20:45:58+00:00 https://biolegacyresearch.com/chinese-ointment-company-falsified-lab-results-fda-says/ 2017-09-27T20:46:50+00:00 https://biolegacyresearch.com/fda-bugged-by-conditions-at-dallas-infusion-pharmacy/ 2017-09-27T20:47:35+00:00 https://biolegacyresearch.com/fda-expands-opioid-prescription-rems-to-ir-formulations/ 2017-09-28T21:43:40+00:00 https://biolegacyresearch.com/no-conception-for-six-months-after-cancer-treatment-fda-advises/ 2017-09-28T21:44:32+00:00 https://biolegacyresearch.com/advisory-committee-finds-insufficient-evidence-for-duchennes-drugs-efficacy/ 2017-09-28T21:45:22+00:00 https://biolegacyresearch.com/fda-tech-team-designed-to-foster-cutting-edge-drugmaking-agency-says/ 2017-09-28T21:46:00+00:00 https://biolegacyresearch.com/bidfb-and-novo-nordisk-as-launch-first-ever-global-survey-on-cardiovascular-disease-awareness-among-people-with-type-2-diabetes/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/how-much-cash-kite-pharmas-execs-made-from-its-12-billion-gilead-deal/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/hill-rom-to-host-fiscal-fourth-quarter-2017-earnings-conference-call-and-webcast/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/as-its-rd-boss-retires-eli-lilly-ceo-taps-an-entirely-new-c-suite-for-2018/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/fda-warns-physicians-on-endoleaks-with-stent-grafts/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-zogenix-explodes-on-late-stage-epilepsy-data/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/motif-biosciences-inc-reports-half-year-2017-financial-results-and-operational-progress/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/2-biotechs-that-turned-7000-into-130200-for-investors/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/syros-pharma-to-present-biomarker-data-from-ongoing-phase-2-clinical-trial-of-sy-1425-at-conference-on-aml/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/almirall-discontinues-rd-for-two-drugs-in-the-u-s/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/merck-co-terminates-hep-c-development-programs/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/bvisualdxba-transformational-artificial-intelligence-app-for-iphone-to-help-improve-diagnosis-of-diseases/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/alere-coughs-up-13-million-to-settle-accounting-fraud-charges-with-the/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/delmar-pharma-announces-fiscal-year-2017-financial-results/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/the-medicines-company-to-present-data-at-on-infectious-disease-portfolio-including-recently-approved-antibiotic-vabomeremeropenem-and-vaborbactam/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/molecularmd-announces-partnership-with-to-support-improved-clinical-trial-histopathology-workflows-integrating-digital-biomarker-analysis-services/ 2017-09-29T00:00:00+00:00 https://biolegacyresearch.com/new-mapp-gives-sponsors-seven-days-to-correct-minor-anda-deficiencies/ 2017-09-29T21:38:47+00:00 https://biolegacyresearch.com/fda-unveils-new-public-dashboard-for-its-faers-database/ 2017-09-29T21:39:31+00:00 https://biolegacyresearch.com/amerisourcebergen-pleads-guilty-in-cancer-drug-ploy/ 2017-09-29T21:40:32+00:00 https://biolegacyresearch.com/amgen-to-delay-humira-biosimilar-until-2023-in-deal-with-abbvie/ 2017-09-29T21:41:22+00:00 https://biolegacyresearch.com/senators-seek-investigation-into-allergans-mohawk-tribe-patent-deal/ 2017-09-29T21:42:13+00:00 https://biolegacyresearch.com/mylan-launches-generic-gleevec-tablets/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/boy-wonder-roivant-bets-116-million-on-arbutus/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/court-sets-the-trial-date-for-mimedx-patent-infringement-lawsuit-against-mtf-medline-and-liventa/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/ksq-emerges-with-76-million-and-will-be-helmed-by-former-ceo/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/status-regarding-novo-nordisk-ass-holding-of-its-own-shares-30-september-2017/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/iconic-sues-nanthealths-over-altor-bioscience-stock-fraud/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/sanofi-appoints-executive-vice-president-diabetes-cardiovascular/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/3-tiny-biotechs-that-could-catch-fire-soon/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/indiana-university-school-of-medicine-awarded-prestigious-2-1-million-grant-to-study-traumatic-brain-injury/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-dynavax-quietly-shops-around-its-almost-approved-hep-b-vaccine/ 2017-10-02T00:00:00+00:00 https://biolegacyresearch.com/fda-guidance-steps-up-push-to-speed-generics-to-market/ 2017-10-02T21:57:54+00:00 https://biolegacyresearch.com/class-action-suit-claims-celgene-gamed-the-system-to-guard-thalomid-revlimid-monopolies/ 2017-10-02T21:59:34+00:00 https://biolegacyresearch.com/judge-refuses-request-for-injunction-against-marylands-generic-price-gouging-law/ 2017-10-02T22:03:13+00:00 https://biolegacyresearch.com/amgen-brings-suit-against-yet-another-neulasta-biosimilar-maker-mylan/ 2017-10-02T22:05:57+00:00 https://biolegacyresearch.com/bcitib-appointed-as-depositary-bank-for-bnightstarsb-adr-programme/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/biotech-upstart-polarityte-buys-huge-site-hopes-to-grow-from-60-to-1000-employees-in-5-years/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/waters-corporation-q3-2017-financial-results-webcast-invitation/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/celgene-cuddles-up-with-another-cambridge-biotech-this-time-to-tackle-autoimmune-diseases/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/mesa-labs-declares-quarterly-dividend/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/the-most-wanted-employers-in-the-san-francisco-bay-area/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/atlas-genetics-taps-life-sciences-vet-as-new-ceo/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/double-duty-fda-head-in-the-running-to-lead-the-after-flightgate-scandal/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/sonoma-pharma-announces-u-s-commercialization-of-loyon-for-relief-of-scaling-burning-and-itching-associated-with-various-dermatoses-including-seborrhea-and-seborrheic-dermatitis/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/belgium-biotech-ablynx-files-for-150-million-u-s-ipo-right-after-phase-iii-boost/ 2017-10-03T00:00:00+00:00 https://biolegacyresearch.com/fda-officials-highlight-compliance-and-warning-letter-trends/ 2017-10-03T21:33:23+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-moves-against-gmp-violators/ 2017-10-03T21:34:31+00:00 https://biolegacyresearch.com/fda-updates-guidelines-on-quality-testing-to-include-health-canada/ 2017-10-03T21:39:00+00:00 https://biolegacyresearch.com/uk-firms-may-have-trouble-lifting-non-compliance-marks-post-brexit/ 2017-10-03T21:39:54+00:00 https://biolegacyresearch.com/expert-lists-data-integrity-red-flags-for-drug-sponsors/ 2017-10-03T21:40:49+00:00 https://biolegacyresearch.com/483-roundup-sterile-conditions-elude-drug-producers-fda-says/ 2017-10-03T21:41:44+00:00 https://biolegacyresearch.com/fda-loosens-expanded-access-requirements-as-gottlieb-testifies-on-right-to-try-bills/ 2017-10-03T22:27:29+00:00 https://biolegacyresearch.com/hhs-delays-340b-rule-again-indicates-it-may-drop-it-per-trump-order/ 2017-10-03T22:28:18+00:00 https://biolegacyresearch.com/house-members-join-probe-in-allergan-mohawk-patent-deal/ 2017-10-03T22:29:08+00:00 https://biolegacyresearch.com/pfizer-loses-suit-against-texas-agency-over-sharing-medicaid-data-with-lawmakers/ 2017-10-03T22:30:10+00:00 https://biolegacyresearch.com/md-anderson-cancer-center-and-bridgebio-launch-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/doing-it-right-the-man-who-blew-up-theranos-started-his-own-medical-testing-biotech/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/dentsply-sirona-chairman-ceo-and-coo-resign-in-management-shakeup/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/bpalleon-pharmab-bursts-onto-the-scene-with-47-6-million-and-a-new-rd-approach/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/brainstorm-cell-to-announce-third-quarter-financial-results-and-provide-corporate-updates-on-tuesday-october-17/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/motif-bio-explodes-after-phase-iii-clinical-trial-success/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/bio-tissue-announces-strategic-agreement-with-to-promote-its-regenerative-healing-technology-in-canada/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/recursion-scores-60-million-to-fund-ai-driven-drug-repurposing-pipeline-development/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/allcells-announces-go-live-implementation-of-oracle-erp-solution/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/amgen-backed-immatics-lands-58-million-to-develop-t-cell-receptor-based-immunotherapies/ 2017-10-04T00:00:00+00:00 https://biolegacyresearch.com/fda-issues-final-pas-and-dmf-guidances-as-gdufa-ii-gets-underway/ 2017-10-04T22:33:46+00:00 https://biolegacyresearch.com/fda-adopts-ich-m4-guideline-on-ectd-organization/ 2017-10-04T22:34:47+00:00 https://biolegacyresearch.com/gilead-seeks-supreme-court-review-of-fca-claims-in-whistleblower-suit/ 2017-10-04T22:35:45+00:00 https://biolegacyresearch.com/aclu-sues-fda-over-abortion-drugs-access-restrictions/ 2017-10-04T22:36:51+00:00 https://biolegacyresearch.com/omeicos-therapeutics-secures-extension-of-series-b-financing-round-to-expand-its-technology-into-ophthalmology/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/acadia-scraps-a-phase-ii-alzheimers-trial-gets-breakthrough-tag-for-dementia-related-drug/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/stanford-neuroscientist-robert-malenka-m-d-ph-d-to-advise-cerevance/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnsons-animas-to-shut-down-ops-and-exit-insulin-pump-biz-410-jobs-affected/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/3m-company-drives-global-design-scale-with-announcement-of-in-japan/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/cambridge-based-biotech-scoops-up-46-7-million-in-funding-round/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/cepheid-wins-fda-nod-to-market-xpert-xpress-strep-a/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/despite-one-death-and-one-adverse-event-bluebird-bios-gene-therapy-study-meets-goals/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/bpharmaseekb-offers-solution-to-slow-payments-in-the-clinical-research-industry/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/rhythms-ipo-exceeds-expections-raises-120-million-in-debut/ 2017-10-05T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-urges-transition-to-abuse-deterrent-opioid-formulations/ 2017-10-05T22:39:54+00:00 https://biolegacyresearch.com/fiscal-2017-ends-with-record-high-in-anda-approvals/ 2017-10-05T22:40:40+00:00 https://biolegacyresearch.com/british-drugmakers-abandon-challenge-to-new-cost-effectiveness-rules/ 2017-10-05T22:41:50+00:00 https://biolegacyresearch.com/bay-area-acerta-pharma-falsified-early-data-on-a-cancer-compound-now-in-clinical-trials/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/qiagen-inc-launches-fourth-generation-quantiferon-tb-gold-plus-in-the-u-s/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/bayer-halts-phase-iii-study-on-new-xarelto-indication/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/milestone-scientific-ceo-steps-down-months-after-taking-job-interim-leader-named/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/outrage-leads-senator-to-draft-bill-in-response-to-allergans-should-be-illegal-patent-maneuver/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/bgendiusb-announces-funding-from-bcatapult-venturesb-to-launch-innovative-digital-health-platform-for-patients-living-with-diabetes/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/bharmony-biosciencesb-gains-u-s-rights-to-pitolisant-raises-270-million/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/newron-pharma-supports-rett-syndrome-awareness-month-this-october/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/where-high-flying-cara-therapeutics-could-be-in-5-years/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/carmat-expands-its-pivotal-study-internationally-in-line-with-its-clinical-strategy-and-ce-marking-process/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/bnorbert-oppitzb-joins-sobi-as-new-senior-vice-president-specialty-care/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/integra-lifesciences-launches-revize-revize-x-collagen-matrix-for-plastic-and-reconstructive-surgery/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/swift-biosciences-doubles-michigan-hq-space-and-opens-up-shop-in-san-francisco/ 2017-10-06T00:00:00+00:00 https://biolegacyresearch.com/fda-to-give-companies-advance-notice-of-generic-rtrs-crls-and-approvals/ 2017-10-06T22:59:32+00:00 https://biolegacyresearch.com/federal-circuit-instructs-pto-to-allow-companies-to-amend-ipr-challenged-patents/ 2017-10-06T23:00:19+00:00 https://biolegacyresearch.com/lilly-prevails-in-patent-challenge-to-alimta-vitamin-regimen/ 2017-10-06T23:01:05+00:00 https://biolegacyresearch.com/mccaskill-bill-seeks-to-close-loophole-that-allowed-allergan-deal-asks-phrma-to-act/ 2017-10-06T23:01:53+00:00 https://biolegacyresearch.com/abbvie-loses-second-consecutive-bellwether-suit-over-androgel-risks/ 2017-10-06T23:02:37+00:00 https://biolegacyresearch.com/why-this-biotech-up-300-since-may-could-be-the-next-big-ma-target/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/si-bone-announces-utahs-public-employees-health-plan-pehp-establishes-coverage-for-the-ifuse-procedure-for-minimally-invasive-si-joint-fusion/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/bio-rad-to-shut-down-cambridge-rd-site-in-consolidation/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/mettler-toledo-to-exhibit-at-annual-conference-in-fort-worth-tx/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/its-official-shire-takes-over-ariads-old-space-in-kendall-square/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/endo-international-to-announce-third-quarter-2017-financial-results/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/scandal-ridden-insys-replaced-90-of-its-original-sales-force-in-makeover/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/can-fite-biopharma-ceo-dr-to-present-as-expert-speaker-at-europe-in-frankfurt-germany-on-october-12-2017/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/proteostasis-and-roche-diagnostics-ink-huge-space-in-new-boston-hub/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/bideal-implantb-release-6-year-data-on-ideal-implant-presented-at-the-annual-meeting-of-the-bamerican-society-of-plastic-surgeryb-in-orlando-fl/ 2017-10-09T00:00:00+00:00 https://biolegacyresearch.com/fda-issues-pas-and-dmf-guidances-as-gdufa-ii-gets-underway/ 2017-10-09T19:51:52+00:00 https://biolegacyresearch.com/court-rejects-abbvie-patent-suits-boosting-ftc-pay-for-delay-claims/ 2017-10-09T20:03:48+00:00 https://biolegacyresearch.com/fda-launches-critical-to-quality-pilot-program/ 2017-10-09T20:23:33+00:00 https://biolegacyresearch.com/epipen-manufacturer-bungled-response-to-complaints-of-failures-fda-says/ 2017-10-09T20:24:24+00:00 https://biolegacyresearch.com/cyber-risk-prompts-abbott-recall-of-465k-pacemakers/ 2017-10-09T20:26:54+00:00 https://biolegacyresearch.com/court-agrees-to-new-trial-over-negligence-claims-against-depuy/ 2017-10-09T20:27:44+00:00 https://biolegacyresearch.com/protecting-devices-from-cybersecurity-risks/ 2017-10-09T20:28:50+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-targets-five-devicemakers/ 2017-10-09T20:29:55+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-six-firms-over-complaints-other-deficiencies/ 2017-10-09T20:31:04+00:00 https://biolegacyresearch.com/fda-releases-final-guidance-on-interoperable-devices/ 2017-10-09T20:32:09+00:00 https://biolegacyresearch.com/brazil-revamps-gmp-inspections-to-improve-access-to-new-technologies/ 2017-10-09T20:33:08+00:00 https://biolegacyresearch.com/fda-officials-show-support-for-risk-based-capa-strategy/ 2017-10-09T20:34:02+00:00 https://biolegacyresearch.com/california-joins-states-looking-to-rein-in-drug-price-hikes/ 2017-10-09T21:54:32+00:00 https://biolegacyresearch.com/china-to-allow-use-of-overseas-trial-data-in-drug-applications/ 2017-10-09T21:55:27+00:00 https://biolegacyresearch.com/ema-updates-listings-of-required-excipient-safety-labeling/ 2017-10-09T21:56:18+00:00 https://biolegacyresearch.com/amgen-asks-court-to-scuttle-genentechs-defense-of-avastin-patents/ 2017-10-09T21:57:04+00:00 https://biolegacyresearch.com/unapproved-ingredients-used-by-washington-state-compounder-fda-says/ 2017-10-09T21:58:09+00:00 https://biolegacyresearch.com/somagenics-inc-awarded-nih-funding-to-develop-ngs-single-cell-analysis-of-small-rnas/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithklines-pharma-chief-lands-job-at-chinese-pe-firm/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/mimedx-adds-new-materials-to-its-website-exposing-misinformation-disseminated-through-short-seller-attacks/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/eli-lilly-dealt-another-setback-as-lung-cancer-drug-flunks-phase-iii-test/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/3d-signatures-announces-completion-of-stage-3-of-hodgkins-lymphoma-test-validation-program/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/spark-therapeutics-revolutionary-gene-therapy-for-blindness-faces-the-fda-on-thursday/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/mauna-kea-technologies-cellvizio-now-ce-marked-for-use-during-robotic-assisted-surgery/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/uks-makes-debut-at/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/final-surviving-claims-in-mimedx-patent-infringement-lawsuit-against-scheduled-to-go-to-trial-in-january-2018/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/medtronic-orders-employees-to-evacuate-california-facilities/ 2017-10-10T00:00:00+00:00 https://biolegacyresearch.com/bts-research-appoints-vp-toxicology-oversee-sponsors-preclinical-tox-programs/ 2017-10-10T22:18:26+00:00 https://biolegacyresearch.com/ema-answers-more-stakeholder-questions-in-lead-up-to-eudravigilance-launch/ 2017-10-10T22:36:30+00:00 https://biolegacyresearch.com/new-jersey-ags-proposal-would-add-new-restrictions-on-drugmakers-gifts/ 2017-10-10T22:37:25+00:00 https://biolegacyresearch.com/group-wants-explanation-for-fdas-speedy-ebola-treatment-decision/ 2017-10-10T22:38:17+00:00 https://biolegacyresearch.com/fda-cites-supplement-company-for-drug-claims/ 2017-10-10T22:39:04+00:00 https://biolegacyresearch.com/rhythm-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/wall-streets-top-biotech-analyst-loves-these-2-life-science-stocks/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/bmike-hoovenb-founder-of-atricure-and-enable-injections-joins-genetesis-board-of-directors/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/lupin-coughs-up-150-million-cash-for-this-new-jersey-based-biopharma/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/janssen-rd-establishes-first-of-its-kind-mobile-medication-and-data-management-technology-platform-for-industry-use/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/why-astrazeneca-plc-ceo-took-a-job-his-friends-called-a-suicide-mission/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/avita-medical-taps-investors-for-a16-9-million-to-commercialise-its-spray-on-skin/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/flexion-eyes-creation-of-100-new-sales-jobs-to-sell-just-approved-osteoarthritis-drug/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/milliporesigma-opens-new-life-science-center-in-massachusetts-for-scientific-collaboration/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/bjanpixb-launches-with-22-million-and-will-be-helmed-by-ex-boehringer-ingelheim-exec/ 2017-10-11T00:00:00+00:00 https://biolegacyresearch.com/340b-program-key-to-serving-the-needy-hospitals-tell-congress/ 2017-10-11T22:04:31+00:00 https://biolegacyresearch.com/fda-releases-updated-guidance-on-rems-formatting/ 2017-10-11T22:05:17+00:00 https://biolegacyresearch.com/fda-outlines-anda-reconsideration-procedures/ 2017-10-11T22:06:08+00:00 https://biolegacyresearch.com/boehringer-questions-fda-guidance-on-child-resistant-packaging-labels/ 2017-10-11T22:07:05+00:00 https://biolegacyresearch.com/bspruce-biosciencesb-provides-corporate-update-on-series-a-venture-financing-leadership-team-and-lead-clinical-program/ 2017-10-12T00:00:00+00:00 https://biolegacyresearch.com/acelrx-stopped-cold-fda-rejects-nda-for-pain-drug-dsuvia-arx-04/ 2017-10-12T00:00:00+00:00 https://biolegacyresearch.com/harvards-ph-d-a-leader-in-alzheimers-disease-genetics-joins-cerevances-advisory-board/ 2017-10-12T00:00:00+00:00 https://biolegacyresearch.com/ardelyx-shares-soared-after-positive-phase-iii-results-for-tenapanor/ 2017-10-12T00:00:00+00:00 https://biolegacyresearch.com/anika-therapeutics-to-issue-third-quarter-2017-financial-results-and-business-highlights-on-wednesday-october-25/ 2017-10-12T00:00:00+00:00 https://biolegacyresearch.com/merck-co-scraps-experimental-cholesterol-drug-anacetrapib/ 2017-10-12T00:00:00+00:00 https://biolegacyresearch.com/wave-life-sciences-to-present-at/ 2017-10-12T00:00:00+00:00 https://biolegacyresearch.com/the-best-career-advice-from-axovants-ceo/ 2017-10-12T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-innovation-releases-impact-report/ 2017-10-12T00:00:00+00:00 https://biolegacyresearch.com/ad-comm-gives-thumbs-up-to-gene-therapy-for-inherited-eye-disease/ 2017-10-12T21:49:17+00:00 https://biolegacyresearch.com/new-fda-advisory-committee-to-develop-standards-for-patient-engagement/ 2017-10-12T21:50:07+00:00 https://biolegacyresearch.com/fda-releases-guidance-for-studies-of-rsv-drugs/ 2017-10-12T21:50:59+00:00 https://biolegacyresearch.com/fda-clarifies-approval-pathways-for-anda-505b2-applications-in-new-draft-guidance/ 2017-10-12T21:51:57+00:00 https://biolegacyresearch.com/massachusetts-biostage-slashes-71-of-staff-evaluating-strategic-alternatives/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/zafgen-reports-inducement-grant-under-nasdaq-listing-rule-5635c4/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/booming-bay-area-biotechs-huge-headache-where-to-house-their-employees/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/bembera-neurotherapeuticsb-to-present-at-the-2017-bio-investor-forum/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/big-pharmas-are-poaching-top-talent-from-tech-giants-like-google-and/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/celsion-to-host-research-and-development-rd-day-on-thursday-october-12-2017/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/nih-hooks-up-with-11-top-biopharmas-for-215-million-cancer-moonshot-deal/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/john-wiley-sons-inc-announces-as-new-evp-of-publishing-business/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/spark-therapeutics-jumps-as-fda-panel-backs-breakthrough-gene-therapy/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/vivasure-medical-enrolls-first-patient-in-frontier-iv-clinical-trial/ 2017-10-13T00:00:00+00:00 https://biolegacyresearch.com/uk-firms-may-have-trouble-lifting-gmp-non-compliance-marks-post-brexit/ 2017-10-13T16:43:00+00:00 https://biolegacyresearch.com/ema-updates-advice-on-chmp-opinions-on-products-for-non-eu-countries/ 2017-10-13T16:49:03+00:00 https://biolegacyresearch.com/ema-to-update-ich-guidelines-on-trial-statistics-reproductive-toxicology/ 2017-10-13T16:50:01+00:00 https://biolegacyresearch.com/fda-updates-ich-quality-testing-guidance-to-include-health-canada/ 2017-10-13T16:54:12+00:00 https://biolegacyresearch.com/fda-committee-votes-in-favor-of-glaucoma-drugs-efficacy/ 2017-10-13T21:35:18+00:00 https://biolegacyresearch.com/fda-guidance-lays-out-requirements-for-anda-post-crl-meetings/ 2017-10-13T21:36:07+00:00 https://biolegacyresearch.com/nih-teams-up-with-biopharma-for-cancer-moonshot/ 2017-10-13T21:36:54+00:00 https://biolegacyresearch.com/chmp-recommends-one-generic-six-label-expansions-at-latest-meeting/ 2017-10-13T21:37:42+00:00 https://biolegacyresearch.com/judge-invalidates-patents-allergan-transferred-to-native-american-tribe/ 2017-10-16T22:58:00+00:00 https://biolegacyresearch.com/ema-details-brexit-continuity-plan-and-staff-retention-efforts/ 2017-10-16T22:59:22+00:00 https://biolegacyresearch.com/sales-of-customized-dietary-supplements-blocked-by-federal-judge/ 2017-10-16T23:00:09+00:00 https://biolegacyresearch.com/judge-rules-actavis-infringed-on-orexigens-contrave-patents/ 2017-10-16T23:00:53+00:00 https://biolegacyresearch.com/ema-paper-outlines-use-of-data-extrapolation-in-pediatric-applications/ 2017-10-16T23:01:43+00:00 https://biolegacyresearch.com/blame-flies-at-capitol-hill-hearing-on-the-reasons-for-high-priced-drugs/ 2017-10-17T21:43:37+00:00 https://biolegacyresearch.com/canadian-drug-regulators-unveil-fee-increases/ 2017-10-17T21:45:25+00:00 https://biolegacyresearch.com/stakeholders-say-fda-guidance-on-post-approval-changes-for-biologics-needs-clarification/ 2017-10-17T21:46:18+00:00 https://biolegacyresearch.com/green-herb-blackened-in-fda-warning-letter/ 2017-10-17T21:47:00+00:00 https://biolegacyresearch.com/fda-flags-vital-laboratories-for-inadequate-storage-training/ 2017-10-17T21:47:57+00:00 https://biolegacyresearch.com/fda-advisory-committee-votes-in-favor-of-novo-nordisks-diabetes-injectable/ 2017-10-18T22:05:48+00:00 https://biolegacyresearch.com/mccaskill-introduces-bill-to-repeal-law-that-weakened-dea-authority-over-opioids/ 2017-10-18T22:06:41+00:00 https://biolegacyresearch.com/court-levies-40-million-judgement-over-deceptive-weight-loss-claims-in-ftc-case/ 2017-10-18T22:07:32+00:00 https://biolegacyresearch.com/fda-blows-the-whistle-on-umich-for-unsterile-conduct/ 2017-10-18T22:08:23+00:00 https://biolegacyresearch.com/fda-approves-second-gene-therapy/ 2017-10-18T22:13:23+00:00 https://biolegacyresearch.com/weeks-after-buying-reshape-medical-for-38m-enteromedics-bags-61m/ 2017-10-19T00:00:00+00:00 https://biolegacyresearch.com/arcturus-rockets-on-new-hep-b-rna-deal-with-johnson-johnson/ 2017-10-19T00:00:00+00:00 https://biolegacyresearch.com/here-is-the-one-biotech-billionaire-investors-love/ 2017-10-19T00:00:00+00:00 https://biolegacyresearch.com/pfizer-quietly-takes-passive-stake-in-this-boston-pharma/ 2017-10-19T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-inks-rd-deal-with-ramaswamys-roivant-for-hush-hush-indication/ 2017-10-19T00:00:00+00:00 https://biolegacyresearch.com/pfizer-gets-incentives-to-keep-a-250-employee-workforce-in-memphis/ 2017-10-19T00:00:00+00:00 https://biolegacyresearch.com/eli-lilly-looks-over-its-shoulder-after-novo-nordisk-wins-fda-panel-backing-for-diabetes-drug/ 2017-10-19T00:00:00+00:00 https://biolegacyresearch.com/uniqure-researchers-swap-out-lead-drug-for-a-better-prospect/ 2017-10-19T00:00:00+00:00 https://biolegacyresearch.com/fda-posts-updated-inspection-manual-chapter/ 2017-10-19T21:24:41+00:00 https://biolegacyresearch.com/fda-issues-draft-bioequivalence-guidances-for-30-drugs-revises-17/ 2017-10-19T21:25:43+00:00 https://biolegacyresearch.com/lawsuit-claims-drugmakers-paid-bribes-that-funded-attacks-on-u-s-troops-in-iraq/ 2017-10-19T21:26:38+00:00 https://biolegacyresearch.com/fda-releases-new-mapp-on-reviewing-packaging-drug-master-files/ 2017-10-19T21:27:38+00:00 https://biolegacyresearch.com/mercks-cyber-attack-could-cost-insurers-275m/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/why-this-pharma-may-be-the-best-car-t-bet-not-gilead/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/astellas-and-universal-cells-ink-124m-rd-pact-for-undisclosed-indication/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/durect-stock-plunges-as-pain-med-fails-phase-iii/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/what-brent-saunders-thinks-about-a-possible-allergan-breakup/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/4-large-cap-pharmas-that-could-post-huge-earnings/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/how-patrick-soon-shiongs-generous-gift-violated-state-laws/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/rumors-swirl-of-a-smith-nephew-takeover-with-stryker-and-medtronic-as-top-buyers/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/azurrx-biopharma-and-mayoly-spindler-announce-ms1819-sd-investigational-medicinal-product-dossier/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/710m-gamble-fails-as-celgene-terminates-two-phase-iii-trials/ 2017-10-20T00:00:00+00:00 https://biolegacyresearch.com/ema-publishes-action-plan-to-streamline-gene-therapy-development-and-review/ 2017-10-20T21:39:55+00:00 https://biolegacyresearch.com/pennsylvania-governor-signs-right-to-try-law/ 2017-10-20T21:40:44+00:00 https://biolegacyresearch.com/indian-generics-manufacturer-fails-to-meet-standards-uk-inspectors-say/ 2017-10-20T21:41:36+00:00 https://biolegacyresearch.com/eu-gmp-measures-for-drugs-clinical-trials-added-to-legal-code/ 2017-10-20T21:42:39+00:00 https://biolegacyresearch.com/company-failed-to-check-out-patients-drug-complaint-fda-says/ 2017-10-20T21:44:02+00:00 https://biolegacyresearch.com/exactech-goes-private-in-625m-deal-with-tpg-capital/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-gets-in-on-adc-therapeutics-mega-200m-funding-round/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/these-3-gene-therapy-biotechs-could-make-investors-rich/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-global-blood-therapeutics-terminates-lung-disease-program/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithklines-shingrix-approved-in-the-u-s-for-prevention-of-shingles-in-adults-aged-50-and/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-novartis-melanoma-combo-drug-a-breakthrough/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/dbv-technologies-crashed-as-allergy-drug-flunked-phase-iii-test/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/takedas-partner-merges-with-crestovo-to-form-finch-therapeutics-group/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/the-5-key-drugs-that-need-to-keep-performing-to-keep-johnson-johnson-on-top/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/eli-lilly-to-invest-72m-in-indianapolis-diabetes-manufacturing/ 2017-10-23T00:00:00+00:00 https://biolegacyresearch.com/boehringer-sues-five-generics-companies-to-protect-its-gilotrif-lung-cancer-therapy/ 2017-10-23T22:49:23+00:00 https://biolegacyresearch.com/emas-prac-recommends-new-safety-warnings-and-side-effect-labeling/ 2017-10-23T22:50:00+00:00 https://biolegacyresearch.com/judge-turns-down-abbotts-motion-in-depakote-birth-defects-case/ 2017-10-23T22:51:06+00:00 https://biolegacyresearch.com/tennessee-judge-denies-endo-request-to-move-opioid-lawsuit-to-federal-court/ 2017-10-23T22:52:01+00:00 https://biolegacyresearch.com/compounder-missed-marks-for-sterile-drug-processing-fda-says/ 2017-10-23T22:52:57+00:00 https://biolegacyresearch.com/puerto-rico-drug-production-still-lagging-badly-gottlieb-tells-congress/ 2017-10-24T21:35:14+00:00 https://biolegacyresearch.com/fda-rolls-out-informational-campaign-on-biosimilars/ 2017-10-24T21:36:02+00:00 https://biolegacyresearch.com/drug-drug-interaction-covered-in-fda-guidances/ 2017-10-24T21:36:55+00:00 https://biolegacyresearch.com/fda-warns-vital-laboratories-for-inadequate-testing-incomplete-production-records/ 2017-10-24T21:37:43+00:00 https://biolegacyresearch.com/the-ido-battle-gets-ugly/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/mis-matched-expectations-with-celgene-ionis/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/investors-may-be-overlooking-this-small-fast-growing-bay-area-biotech/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/vexim-acquired-by-stryker-in-eur-183m-deal/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/lysogene-pushes-forward-with-sanfilippo-syndrome-study-establishes-footprint-in-u-s/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/george-scangos-bold-vision/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/ablynx-banks-200m-ipo-in-nasdaq-debut/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/the-medicines-company-slashes-hundreds-of-jobs-in-restructuring/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/why-even-spinraza-cant-save-biogens-incoming-ms-meltdown/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/this-massachusetts-marijuana-biotech-is-betting-the-farm-on-one-single-drug/ 2017-10-25T00:00:00+00:00 https://biolegacyresearch.com/proposed-nj-rule-to-limit-drugmaker-payment-to-doctors-could-hurt-drug-development-acro-warns/ 2017-10-25T21:34:41+00:00 https://biolegacyresearch.com/florida-compounding-pharmacy-broke-gmp-rules-fda-says/ 2017-10-25T21:35:28+00:00 https://biolegacyresearch.com/democratic-lawmakers-introduce-medicare-price-negotiation-bill/ 2017-10-25T21:49:05+00:00 https://biolegacyresearch.com/fda-to-help-break-the-stigma-of-drug-assisted-opioid-addiction-treatments/ 2017-10-25T21:52:01+00:00 https://biolegacyresearch.com/the-6-most-in-demand-biotech-jobs-right-now/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/investors-spooked-celgene-plummets-after-slashing-its-2020-guidance/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/despite-9b-setback-eli-lilly-boldly-moves-on-with-five-new-alzheimers-candidates/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/siemens-summons-three-banks-for-ipo-of-healthineers-unit/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/pfizers-15b-consumer-health-biz-may-be-on-glaxosmithklines-shopping-list/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/top-10-best-locations-for-life-science-jobs-in-the-world/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/abbvie-touts-late-stage-psoriasis-drug-trial-data/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/bluerock-therapeutics-sets-up-hq-in-cambridge-expands-executive-team/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-biomarins-hemophilia-a-drug-a-breakthrough/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/teva-makes-move-to-block-eli-lilly-from-bringing-its-migraine-drug-to-the-u-s/ 2017-10-26T00:00:00+00:00 https://biolegacyresearch.com/trump-officially-declares-opioid-epidemic-a-public-health-emergency/ 2017-10-26T22:04:23+00:00 https://biolegacyresearch.com/insys-founder-charged-with-nationwide-conspiracy-to-push-fentanyl-prescriptions/ 2017-10-26T22:05:10+00:00 https://biolegacyresearch.com/fda-publishes-guidance-for-developing-gastroesophageal-reflux-treatments-in-children/ 2017-10-26T22:05:57+00:00 https://biolegacyresearch.com/eu-pediatric-drug-rule-produces-mixed-results-report-says/ 2017-10-26T22:06:45+00:00 https://biolegacyresearch.com/why-this-pharma-surged-after-trumps-opioid-declaration/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/cambridge-based-wave-life-sciences-expands-into-new-facility-designed-to-house-up-to-200-employees/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/billionaire-insys-founder-charged-with-bribing-doctors-to-prescribe-opioid-painkillers/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/gilead-hcv-woes-continue-and-investors-are-spooked/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/booming-regeneron-to-hire-300-new-workers-in-ireland/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-versartis-cuts-jobs-and-cancels-contracts-as-it-evaluates-a-path-forward/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/china-based-kb-biotech-solutions-to-bring-100-new-jobs-to-south-carolina/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/this-tiny-massachusetts-biotech-could-reap-big-rewards-for-investors/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/kitov-pharma-surges-as-lead-drug-hits-goals-in-phase-iii-test/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/meet-the-top-5-drug-delivery-companies-with-their-latest-projects-and-products/ 2017-10-27T00:00:00+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-gdufa-ii-fee-payments-and-consequences/ 2017-10-27T21:55:12+00:00 https://biolegacyresearch.com/teva-sues-eli-lilly-for-patent-infringement-over-migraine-drug/ 2017-10-27T21:56:07+00:00 https://biolegacyresearch.com/mylan-claims-another-victory-over-teva-on-copaxone-patents/ 2017-10-27T21:56:58+00:00 https://biolegacyresearch.com/emas-prac-recommends-additional-zinbryta-restrictions/ 2017-10-27T21:58:13+00:00 https://biolegacyresearch.com/judge-throws-out-claims-of-anticompetitive-behavior-against-suboxone-maker/ 2017-10-27T21:59:16+00:00 https://biolegacyresearch.com/regulatory-update-2/ 2017-10-27T22:02:00+00:00 https://biolegacyresearch.com/sumitomo-dainippon-pharma-poxel-ink-300m-diabetes-pact/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/merck-drops-after-withdrawing-european-app-for-wonder-drug-keytruda/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/kymera-emerges-out-of-stealth-mode-with-30m-and-a-top-team-of-drug-hunters/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/shire-in-talks-to-sell-100-employee-facility-in-massachusetts/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/this-is-the-fastest-growing-private-pharma-in-the-bay-area/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/insys-sales-execs-allegedly-made-a-rap-video-of-themselves-dancing-with-their-deadly-fentanyl-spray/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/why-amazon-could-be-more-interested-in-medical-devices-than-drugs/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/the-complicated-relationship-between-celgene-and-president-trump/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/fosun-pharma-to-buy-frances-tridem-for-73m/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-continues-to-divest-assets-takes-stake-in-mereo-biopharma-with-new-deal/ 2017-10-30T00:00:00+00:00 https://biolegacyresearch.com/fda-to-consider-new-requirements-for-opioid-packaging-to-limit-exposure/ 2017-10-30T21:45:21+00:00 https://biolegacyresearch.com/fda-to-adopt-ich-e9-addendum-on-clinical-trials-analyses/ 2017-10-30T21:46:12+00:00 https://biolegacyresearch.com/ema-issues-new-guideline-on-rsv-products/ 2017-10-30T21:47:07+00:00 https://biolegacyresearch.com/ema-drops-requirement-for-testing-untreated-hemophilia-patients-in-draft-guidelines/ 2017-10-30T21:48:05+00:00 https://biolegacyresearch.com/endo-subsidiaries-sue-fda-to-have-agencys-compounding-decree-declared-illegal/ 2017-10-30T21:49:02+00:00 https://biolegacyresearch.com/cancer-biotech-apellis-pharma-sets-terms-for-150m-ipo/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-bloodied-celgene-could-take-out/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/sanofi-dupilumab-significantly-reduced-steroid-use-asthma-attacks-and-improved-lung-function-i/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/voyager-sinks-as-sanofi-genzyme-opts-out-of-parkinsons-gene-therapy-program/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/stemline-therapeutics-announces-that-pivotal-trial-of-sl-401-in-blastic-plasmacytoid-dendritic-ce/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plots-crucial-ido-phase-iii-combo-trial-with-incyte/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/kirin-cashes-out-of-amgen-drug-joint-venture-for-780m/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/daiichi-sankyos-tumor-drug-meets-primary-endpoint-in-late-stage-study/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-johnson-johnson-get-in-on-europeon-biotech-funds-95m-raise/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/lundbeck-names-interim-leader-effective-nov-1-2017/ 2017-10-31T00:00:00+00:00 https://biolegacyresearch.com/fda-to-recognize-gmp-inspections-from-eight-eu-countries/ 2017-10-31T21:57:01+00:00 https://biolegacyresearch.com/monthly-opioid-abuse-treatment-wins-fda-advisory-committee-ok/ 2017-10-31T21:57:50+00:00 https://biolegacyresearch.com/brexit-taking-early-effect-on-ema/ 2017-10-31T21:58:42+00:00 https://biolegacyresearch.com/union-sues-jj-for-blocking-biosimilar-generics-competition/ 2017-10-31T21:59:37+00:00 https://biolegacyresearch.com/ptab-reverses-decision-grants-inter-partes-review-of-herceptin-patent/ 2017-10-31T22:00:24+00:00 https://biolegacyresearch.com/non-profit-petitions-ptab-for-review-of-gileads-hep-c-antiviral-patents/ 2017-10-31T22:01:11+00:00 https://biolegacyresearch.com/ftc-report-number-of-pay-for-delay-settlements-continue-to-drop/ 2017-11-01T22:46:26+00:00 https://biolegacyresearch.com/fda-advisory-committee-sends-mixed-signals-on-braeburn-opioid-mat/ 2017-11-01T22:47:24+00:00 https://biolegacyresearch.com/nice-publishes-recommendations-for-opdivo-kevzara-and-eylea/ 2017-11-01T22:48:29+00:00 https://biolegacyresearch.com/states-widen-generics-price-fixing-lawsuit-name-names/ 2017-11-01T22:49:39+00:00 https://biolegacyresearch.com/ema-revises-2009-guideline-on-axial-spondyloarthritis-treatments/ 2017-11-01T22:50:30+00:00 https://biolegacyresearch.com/fda-sticks-breakthrough-tag-on-glaxosmithklines-blood-cancer-drug/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/mallinckrodt-pays-117m-for-this-bay-area-biotech-and-its-failed-liver-drug/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/fda-grants-orphan-drug-designation-for-retrotopes-rt001-in-the-treatment-of-phospholipase-2g6-p/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/within-our-backyard-finding-solutions-to-overcome-research-resistance/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/late-stage-life-sciences-investment-firm-aisling-capital-closes-280m-fund/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/dicerna-could-pocket-201m-in-nash-rd-deal-with-boehringer-ingelheim/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/sanofi-falls-short-of-q3-expectations-terminates-phase-ii-lung-drug-from-pipeline/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/cambridges-proteostasis-slashes-rd-jobs-in-focus-shift/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/one-time-car-t-leader-juno-shows-off-promising-new-clinical-data/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/biogens-early-stage-alzheimers-data-continues-to-impress/ 2017-11-02T00:00:00+00:00 https://biolegacyresearch.com/fda-updates-generics-correspondence-guidance-for-gdufa-ii/ 2017-11-02T22:10:12+00:00 https://biolegacyresearch.com/fdas-morrison-says-ora-reorganization-will-mean-more-foreign-inspections/ 2017-11-02T22:10:56+00:00 https://biolegacyresearch.com/cms-cuts-2018-340b-reimbursements-to-asp-minus-22-5-percent/ 2017-11-02T22:11:52+00:00 https://biolegacyresearch.com/house-tax-reform-bill-axes-orphan-drug-research-tax-credit/ 2017-11-02T22:12:38+00:00 https://biolegacyresearch.com/fda-slaps-four-companies-for-marketing-cannabidiol-products-as-disease-treatments/ 2017-11-02T22:13:32+00:00 https://biolegacyresearch.com/booming-drug-sales-make-this-san-diego-biotech-a-prime-ma-target/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/biogen-poaches-merck-exec-to-lead-new-marketing-team/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/how-gilead-lost-7-8b-in-october-alone/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/torrent-pharma-coughs-up-558m-for-unichems-india-biz/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/cryogenic-logistics-company-cryoport-grabs-contracts-for-gilead-novartis-car-t-products/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/ionis-announces-submission-of-marketing-authorization-application-for-inotersen-to-the-ema/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/mysterious-moderna-hints-at-its-ipo-timeline/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-zymergen-opens-up-shop-in-seattle-to-accommodate-growth/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/alnylam-emerges-as-winner-in-rare-disease-study-showdown-with-ionis/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/actor-chuck-norris-sues-medical-device-manufacturers-for-allegedly-poisoning-his-wife/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/sarepta-therapeutics-and-nationwide-childrens-hospital-announce-fda-clearance-of-the-ind-applica/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/amgen-novartis-rev-up-for-new-alzheimers-study/ 2017-11-03T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-pitches-restructuring-drug-centers-team-based-reviews/ 2017-11-03T21:33:47+00:00 https://biolegacyresearch.com/data-integrity-is-mission-critical-fda-enforcer-says/ 2017-11-03T21:34:33+00:00 https://biolegacyresearch.com/fda-updates-priority-anda-pre-submission-guidance-for-gdufa-ii/ 2017-11-03T21:35:24+00:00 https://biolegacyresearch.com/fda-guidance-outlines-formal-dispute-appeal-process/ 2017-11-03T21:36:22+00:00 https://biolegacyresearch.com/fda-will-widen-expanded-access-tool-to-cover-orphan-drugs/ 2017-11-03T21:37:09+00:00 https://biolegacyresearch.com/varian-inks-50m-multi-year-project-deal/ 2017-11-06T00:00:00+00:00 https://biolegacyresearch.com/gates-and-his-rich-buddies-back-exicures-11-2m-funding-round/ 2017-11-06T00:00:00+00:00 https://biolegacyresearch.com/valeant-sells-sprout-pharma-to-a-new-company-associated-with-sprout-founders/ 2017-11-06T00:00:00+00:00 https://biolegacyresearch.com/billionaire-businessman-looking-to-take-stake-in-debt-ridden-teva/ 2017-11-06T00:00:00+00:00 https://biolegacyresearch.com/two-year-old-biotech-nouscom-nabs-49m-to-fund-new-drug-into-clinic/ 2017-11-06T00:00:00+00:00 https://biolegacyresearch.com/therapeuticsmd-soars-on-plans-to-resubmit-tx-004hr-nda-without-new-pre-approval-study/ 2017-11-06T00:00:00+00:00 https://biolegacyresearch.com/the-battle-between-two-1b-biotech-unicorns/ 2017-11-06T00:00:00+00:00 https://biolegacyresearch.com/politically-connected-patrick-soon-shiong-questioned-over-genetic-tests/ 2017-11-06T00:00:00+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-for-developing-hepatitis-c-antivirals/ 2017-11-06T22:55:19+00:00 https://biolegacyresearch.com/fda-inspection-agreement-with-eu-frees-up-investigators-for-rest-of-world/ 2017-11-06T22:56:07+00:00 https://biolegacyresearch.com/fda-study-continuing-education-programs-can-meet-rems-requirements/ 2017-11-06T22:57:05+00:00 https://biolegacyresearch.com/judge-denies-summary-judgment-in-lawsuit-over-pay-for-delay-deal/ 2017-11-06T22:57:53+00:00 https://biolegacyresearch.com/outsourcer-broke-rules-for-cgmp-sterile-production-fda-says/ 2017-11-06T22:59:19+00:00 https://biolegacyresearch.com/fda-approves-genentechs-zelboraf-the-first-ever-drug-to-treat-specific-rare-blood-disease/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/roche-lays-off-235-employees-in-switzerland/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-haemonetics-to-eliminate-350-jobs/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/the-lone-3-big-pharmas-that-will-gain-market-share-over-the-next-few-years/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/ai-takes-off-in-biotech-creating-demand-for-high-paying-jobs-of-500k-plus/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/genentechs-frontline-alecensa-approved-for-non-small-cell-lung-cancer/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/senator-harris-scrutinizes-how-alkermes-pushed-its-opioid-addiction-drug/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/takeda-portal-instruments-ink-100m-deal-to-develop-needle-free-drug-delivery-device/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/confident-bristol-myers-to-launch-700-patient-phase-iii-ido-trial-for-melanoma/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/counsyl-celebrates-anniversary-with-80m-funding-round/ 2017-11-07T00:00:00+00:00 https://biolegacyresearch.com/potus-already-has-power-dod-seeks-in-controversial-drug-proposal-professor-says/ 2017-11-07T22:39:41+00:00 https://biolegacyresearch.com/republicans-democrats-gang-up-on-allergan-at-u-s-house-hearing/ 2017-11-07T22:40:34+00:00 https://biolegacyresearch.com/gao-recommends-wider-look-at-opioid-use-by-medicare-beneficiaries/ 2017-11-07T22:41:34+00:00 https://biolegacyresearch.com/lawsuit-allergan-artificially-inflated-stock-amid-price-fixing-conspiracy/ 2017-11-07T22:42:34+00:00 https://biolegacyresearch.com/fda-invites-comments-on-clinical-data-template/ 2017-11-07T22:58:49+00:00 https://biolegacyresearch.com/why-tevas-stock-could-crash-another-50/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/effective-immediately-oncosec-names-former-advaxis-exec-as-new-ceo/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/amgen-leaps-into-the-world-of-regenerative-medicine-with-new-investment/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/tiny-oncosec-surges-on-promising-phase-ii-melanoma-data/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/cantrell-drug-company-files-for-chapter-11-bankruptcy/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/five-prime-tanked-on-early-peek-of-lead-drug-data/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-tricia-closes-57-5m-series-d-pushes-into-phase-iii-trial/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/hedge-fund-takes-another-shot-at-biotech-this-time-at-prothena/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/cambridges-exonics-therapeutics-scores-40m/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/editas-ceo-to-testify-at-a-u-s-senate-hearing-next-week/ 2017-11-08T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-to-delayers-of-generics-end-the-shenanigans/ 2017-11-08T23:56:00+00:00 https://biolegacyresearch.com/fda-takes-aim-at-branded-drugmakers-delaying-tactics-on-shared-rems/ 2017-11-08T23:57:00+00:00 https://biolegacyresearch.com/survey-shows-companies-aim-to-increase-range-of-patient-data-in-clinical-trials/ 2017-11-08T23:59:40+00:00 https://biolegacyresearch.com/siemens-to-replace-healthineers-cfo-in-preparation-for-listing/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/this-is-the-average-interview-process-time-for-a-biopharma-job/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-principia-biopharma-scores-765m-ms-licensing-deal-with-drug-giant-sanofi/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithklines-pain-in-china-is-astrazenecas-gain/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/sage-therapeutics-stock-rockets-on-two-positive-phase-iii-trials-in-postpartum-depression/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-poaches-new-cso-from-googles-calico/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/recipharm-to-end-operations-at-two-swedish-facilities-225-employees-affected/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/german-biotech-inflarx-snags-100m-in-ipo/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/after-40m-financing-exonics-therapeutics-to-start-hiring-for-cambridge-lab/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/jj-exec-reveals-how-you-can-stand-out-among-3000-job-seekers/ 2017-11-09T00:00:00+00:00 https://biolegacyresearch.com/danes-shutter-drug-importer-over-quality-issues/ 2017-11-09T00:01:10+00:00 https://biolegacyresearch.com/fda-expands-anda-prioritization-policy/ 2017-11-09T22:09:39+00:00 https://biolegacyresearch.com/ptab-sides-with-amneal-on-obviousness-of-purdues-oxycontin-patent/ 2017-11-09T22:11:08+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-on-evaluating-drug-effects-on-driving-ability/ 2017-11-09T22:12:03+00:00 https://biolegacyresearch.com/fda-to-revise-20-year-old-ich-reproductive-risks-guideline/ 2017-11-09T22:13:03+00:00 https://biolegacyresearch.com/global-med-device-leader-anthrex-reveals-big-expansion-plans/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/booming-abeona-plans-to-hire-dozens-of-new-employees-in-expansion/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/im-therapeutics-spins-out-of-university-of-colorado-to-focus-on-type-1-diabetes/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/sangamo-inks-deal-for-new-hq-in-bay-area-biotech-hub/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/how-sweet-it-is-dynavax-finally-wins-fda-ok-for-hep-b-vaccine-heplisav/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/as-the-ido-battle-gets-ugly-bristol-myers-shows-off-early-data-for-combo-trial/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/valeant-providing-reporters-with-an-earnings-metric-the-sec-ordered-it-to-stop-using/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/former-eli-lilly-exec-expected-to-be-named-trumps-hhs-secretary/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/how-glaxosmithkline-lost-nearly-10b-in-october/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/sunovion-announces-fda-acceptance-for-review-of-new-drug-application-for-dasotraline-for-the-trea/ 2017-11-10T00:00:00+00:00 https://biolegacyresearch.com/senate-tax-plan-keeps-but-modifies-orphan-research-tax-credit/ 2017-11-10T22:27:32+00:00 https://biolegacyresearch.com/chmp-recommends-ten-medicines-for-approval/ 2017-11-10T22:29:23+00:00 https://biolegacyresearch.com/appeals-court-rules-generic-label-would-direct-docs-to-infringe-use-patent/ 2017-11-10T22:33:50+00:00 https://biolegacyresearch.com/fda-raps-guangdong-firm-over-quality-testing/ 2017-11-10T22:34:43+00:00 https://biolegacyresearch.com/viguard-health-petitions-fda-to-classify-ind-as-a-supplement/ 2017-11-10T22:35:50+00:00 https://biolegacyresearch.com/top-5-biosimilars-drug-stocks-to-buy-right-now/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/tiny-zymeworks-snags-1-4b-rd-deal-with-drug-giant-johnson-johnson/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/top-3-best-biotechs-of-2018/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/pfizer-to-hire-up-to-400-in-michigan-for-2018/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/gates-pledges-100m-to-the-holy-grail-of-science-alzheimers/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/novo-nordisk-lays-off-185-employees-hiring-70-in-commercial-reorg/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/nektar-stock-blows-up-on-encouraging-data-to-treat-difficult-cancers/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-arcus-biosciences-scores-107m-initiates-two-clinical-trials/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/lessons-learned-one-time-leader-juno-uses-deaths-to-create-a-better-car-t-formula/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/argos-surges-on-positive-phase-iii-kidney-cancer-data/ 2017-11-13T00:00:00+00:00 https://biolegacyresearch.com/emas-prac-recommends-new-safety-warnings-side-effect-labeling/ 2017-11-13T18:15:35+00:00 https://biolegacyresearch.com/fda-releases-new-mapp-for-the-review-of-packaging-master-files/ 2017-11-13T18:19:42+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-flags-six-firms-for-numerous-violations/ 2017-11-13T18:21:19+00:00 https://biolegacyresearch.com/483-roundup-fda-finds-faults-during-on-site-inspections/ 2017-11-13T18:22:50+00:00 https://biolegacyresearch.com/biologics-stakeholders-seek-clearer-guidance-on-post-approval-changes/ 2017-11-13T18:30:32+00:00 https://biolegacyresearch.com/cdrh-eyes-quality-program-alignment-for-2018-inspections/ 2017-11-13T18:44:48+00:00 https://biolegacyresearch.com/apple-fitbit-among-fdas-picks-for-device-software-pre-certification-pilot/ 2017-11-13T18:45:57+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-four-firms-over-gmps-capas/ 2017-11-13T18:50:37+00:00 https://biolegacyresearch.com/fda-proposes-framework-for-quality-manufacturing-pilot-program/ 2017-11-13T18:53:09+00:00 https://biolegacyresearch.com/dhs-warns-of-cybersecurity-risks-in-boston-scientific-cardiac-systems/ 2017-11-13T18:54:20+00:00 https://biolegacyresearch.com/483-roundup-fda-targets-seven-devicemakers-for-noncompliance/ 2017-11-13T18:56:09+00:00 https://biolegacyresearch.com/fda-clarifies-when-new-510ks-are-required-for-device-changes/ 2017-11-13T18:57:10+00:00 https://biolegacyresearch.com/health-canada-tweaks-mdsap-to-reduce-audit-times/ 2017-11-13T19:00:07+00:00 https://biolegacyresearch.com/philips-agrees-to-suspend-defibrillator-production-in-ma-wa/ 2017-11-13T19:01:12+00:00 https://biolegacyresearch.com/trump-names-ex-lilly-executive-alex-azar-as-pick-for-next-hhs-secretary/ 2017-11-13T22:57:00+00:00 https://biolegacyresearch.com/ptab-issues-new-rule-governing-attorney-client-privilege/ 2017-11-13T22:59:33+00:00 https://biolegacyresearch.com/ema-and-eunethta-publish-joint-work-plan/ 2017-11-13T23:00:22+00:00 https://biolegacyresearch.com/fda-warns-home-infusion-company/ 2017-11-13T23:01:14+00:00 https://biolegacyresearch.com/fda-flags-outsourcer-for-cybersecurity-and-labeling-issues/ 2017-11-13T23:02:01+00:00 https://biolegacyresearch.com/run-by-former-genentech-employees-bay-areas-denali-seeks-100m-ipo/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/its-official-president-trump-names-former-eli-lilly-exec-hhs-secretary/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/meet-the-4-biotechs-that-are-disrupting-healthcare/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/cambridges-immusant-nabs-40m/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/real-estate-developers-eye-bostons-south-end-for-life-science-campus/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-who-why-a-marriage-between-pfizer-and-biogen-makes-more-sense/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/embattled-mylan-chops-another-200-to-300-jobs/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-avinger-axes-jobs-q3-sales-down-61/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/novartis-showcases-4-potential-blockbusters-in-its-late-stage-pipeline/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/pfizer-creates-coo-role-for-ceo-ian-reads-rumored-successor/ 2017-11-14T00:00:00+00:00 https://biolegacyresearch.com/fda-looks-to-boost-industry-competition-through-deregulation/ 2017-11-14T22:43:11+00:00 https://biolegacyresearch.com/pioneering-digital-pill-receives-fda-approval/ 2017-11-14T22:44:02+00:00 https://biolegacyresearch.com/first-month-of-gdufa-ii-sees-large-spike-in-generic-crls/ 2017-11-14T22:45:04+00:00 https://biolegacyresearch.com/ema-advises-drug-companies-how-to-transfer-orphan-designations/ 2017-11-14T22:45:54+00:00 https://biolegacyresearch.com/astrazeneca-gets-another-boost-with-fda-approval-of-severe-asthma-drug/ 2017-11-15T00:00:00+00:00 https://biolegacyresearch.com/san-diegos-mirati-therapeutics-abandons-lead-drug-shifts-focus/ 2017-11-15T00:00:00+00:00 https://biolegacyresearch.com/meet-the-5-bay-area-biotech-entrepreneurs-under-30/ 2017-11-15T00:00:00+00:00 https://biolegacyresearch.com/amgens-repatha-reduces-cardiovascular-events-in-patients-with-a-history-of-heart-attacks/ 2017-11-15T00:00:00+00:00 https://biolegacyresearch.com/genentech-dumps-another-650m-in-new-haven-biotech-arvinas/ 2017-11-15T00:00:00+00:00 https://biolegacyresearch.com/how-we-talk-about-science-and-science-denial/ 2017-11-15T00:00:00+00:00 https://biolegacyresearch.com/sangamo-scores-bragging-rights-for-first-in-human-gene-editing-trial/ 2017-11-15T00:00:00+00:00 https://biolegacyresearch.com/cambridge-startup-inozyme-nabs-49m-and-a-roster-packed-with-seasoned-vets/ 2017-11-15T00:00:00+00:00 https://biolegacyresearch.com/cardinal-health-unloads-china-biz-to-shanghai-pharma-in-1-2b-deal/ 2017-11-15T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-embraces-new-regulatory-approaches-in-oncology-cell-therapies-and-across-the-agency/ 2017-11-15T22:27:55+00:00 https://biolegacyresearch.com/fda-outlines-bsufa-ii-fee-structure-in-draft-guidance/ 2017-11-15T22:29:00+00:00 https://biolegacyresearch.com/ema-maps-steps-for-improving-product-information-for-patients/ 2017-11-15T22:30:16+00:00 https://biolegacyresearch.com/fdas-benefit-risk-framework-is-good-but-needs-work-bio-says/ 2017-11-15T22:31:12+00:00 https://biolegacyresearch.com/indian-generics-producer-missed-mark-on-tests-fda-says/ 2017-11-15T22:32:30+00:00 https://biolegacyresearch.com/merit-medical-coughs-up-100m-for-bard-bds-biopsy-assets/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/fda-berates-lupin-for-repeatedly-making-pills-that-dont-meet-quality-standards/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/with-merck-footing-the-200m-bill-moderna-launches-mrna-cancer-vaccine-clinical-trial/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/johns-hopkins-gets-a-65m-boost-to-take-promising-drugs-into-clinic/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/verily-ranked-1-for-interesting-meaningful-work-and-competitive-salary/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/regeneron-gets-ok-for-huge-expansion-in-greenburgh-new-york/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/founded-by-genzyme-alumni-cambridges-x4-pharma-scores-27m/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/philadelphia-biotech-startup-context-therapeutics-names-a-new-cfo-effective-immediately/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/all-systems-go-johnson-johnson-reaches-out-for-second-ionis-gi-drug/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/dont-stop-believing-tevas-rd-head-gives-3-reasons-why-investors-should-hold-on/ 2017-11-16T00:00:00+00:00 https://biolegacyresearch.com/fda-lays-out-requirements-for-anda-post-crl-meetings/ 2017-11-16T17:36:35+00:00 https://biolegacyresearch.com/fda-clarifies-approval-pathways-for-applications-in-new-draft-guidance/ 2017-11-16T17:37:32+00:00 https://biolegacyresearch.com/fda-to-give-advance-notice-of-rtrs-crls-and-approvals/ 2017-11-16T17:39:46+00:00 https://biolegacyresearch.com/judge-denies-injunction-against-maryland-price-gouging-law/ 2017-11-16T17:40:40+00:00 https://biolegacyresearch.com/fda-to-help-break-the-stigma-of-opioid-addiction-mats/ 2017-11-16T17:41:29+00:00 https://biolegacyresearch.com/class-action-claims-celgene-gamed-the-system-to-guard-thalomid-revlimid/ 2017-11-16T17:42:24+00:00 https://biolegacyresearch.com/fda-proposes-new-regulatory-framework-for-regenerative-medicine/ 2017-11-16T22:56:00+00:00 https://biolegacyresearch.com/house-approves-tax-bill-that-ends-orphan-drug-credit/ 2017-11-16T22:56:43+00:00 https://biolegacyresearch.com/bill-on-use-of-new-drugs-for-soldiers-heads-to-white-house/ 2017-11-16T22:57:34+00:00 https://biolegacyresearch.com/fda-committee-votes-against-bayers-cipro-inhalation-powder/ 2017-11-16T22:58:24+00:00 https://biolegacyresearch.com/oncolytics-biotech-adlai-nortye-forge-86-6m-reolysin-deal/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/how-celgene-could-reap-huge-rewards-from-this-tiny-biotech/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/meet-the-6-powerful-bay-area-biotech-vcs-youve-never-heard-about/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/why-gilead-should-keep-an-eye-on-junos-new-car-t-strategy/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/sec-filings-reveal-glaxosmithklines-13-stake-in-this-massachusetts-biotech/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/on-a-roll-fda-oks-genentechs-gazyva-for-untreated-follicular-lymphoma/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/pfizer-wins-expanded-fda-nod-for-cancer-drug-sutent/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/takeda-ceo-actively-hunts-for-deals-looks-to-shed-non-core-businesses/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/eli-lilly-insulin-drug-price-tripled-while-trumps-hhs-nominee-was-president-of-the-u-s-unit/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/arbutus-lnp-licensee-alnylam-initiates-rolling-submission-of-nda-to-u-s-fda-for-patisiran/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/scpharmaceuticals-nabs-89-6m-in-ipo/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/fda-extends-review-for-lipocines-tlando-advisory-committee-meeting-date-of-january-10-2018-rem/ 2017-11-17T00:00:00+00:00 https://biolegacyresearch.com/cms-proposes-to-cut-costs-for-medicare-drugs-rein-in-opioids/ 2017-11-17T22:57:04+00:00 https://biolegacyresearch.com/ema-publishes-qa-on-periodic-safety-update-reports-previews-possible-gvp-update/ 2017-11-17T22:58:04+00:00 https://biolegacyresearch.com/judge-denies-compounders-motion-to-dismiss-allergans-false-advertising-complaint/ 2017-11-17T22:59:03+00:00 https://biolegacyresearch.com/insurance-broker-claims-lilly-trained-nurse-educators-to-push-its-drugs/ 2017-11-17T22:59:59+00:00 https://biolegacyresearch.com/store-club-card-not-a-valid-drugmaking-tool-fda-warns-compounder/ 2017-11-17T23:01:03+00:00 https://biolegacyresearch.com/dbv-technologies-surges-as-peanut-allergy-drug-passes-phase-iii-test/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/alnylam-gets-vip-status-as-the-fda-slaps-breakthrough-tag-on-patisiran/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/kamada-chiesi-farmaceutici-terminate-inhaled-alpha-1-antitrypsin-therapy-deal/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/japans-peptidream-bags-1-11b-rd-pact-with-bayer/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/genentech-shows-off-positive-results-from-phase-iii-hemlibra-tecentriq-studies/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/3-top-drugmakers-leading-lung-cancer-rd-right-now/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/why-this-maryland-biotech-could-double-its-stock-by-2018/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/genentech-gets-a-phase-iii-win-with-hemophila-a-drug-hemlibra/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/gamida-cell-taps-former-clal-biotech-cso-as-new-leader/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-pellepharm-wins-fda-breakthrough-tag-for-genetic-rare-disease-drug/ 2017-11-20T00:00:00+00:00 https://biolegacyresearch.com/british-companies-nix-challenge-to-new-cost-effectiveness-rules/ 2017-11-20T21:51:22+00:00 https://biolegacyresearch.com/indian-generics-manufacturer-failed-to-meet-standards-u-k-inspectors-say/ 2017-11-20T21:55:20+00:00 https://biolegacyresearch.com/ema-drops-reqs-for-testing-untreated-patients-in-hemophilia/ 2017-11-20T21:57:50+00:00 https://biolegacyresearch.com/pto-instructed-to-allow-companies-to-amend-ipr-challenged-patents/ 2017-11-20T21:59:15+00:00 https://biolegacyresearch.com/the-ema-gets-a-new-home-amsterdam/ 2017-11-20T22:42:23+00:00 https://biolegacyresearch.com/ema-expands-safety-guidance-for-developing-anticancer-drugs/ 2017-11-20T22:43:06+00:00 https://biolegacyresearch.com/new-york-indicts-pharmacist-pharmacy-owner-for-stealing-from-medicaid/ 2017-11-20T22:43:55+00:00 https://biolegacyresearch.com/fda-flags-drugmaking-problems-at-chinese-company/ 2017-11-20T22:44:40+00:00 https://biolegacyresearch.com/amerisourcebergen-pays-815m-cash-for-drug-wholesaler-h-d-smith/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/meet-the-under-the-radar-biotech-with-a-novel-alzheimers-candidate/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/biogen-taps-biotech-vet-as-new-cfo/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/tiny-corbus-aims-to-have-four-drugs-in-mid-to-late-stage-development-by-next-year/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/palatin-forges-40-5m-deal-with-koreas-kwangdong-pharma/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-that-have-investors-grinning-at-thanksgiving-dinner-this-year/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/cytokinetics-scraps-lead-als-drug-after-late-stage-trial-failure/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/stanford-nci-researchers-discover-new-car-t-target-with-early-study-data/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/amsterdam-named-the-new-home-of-the-ema/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/medtech-innovative-health-solutions-to-create-new-jobs-in-expansion/ 2017-11-21T00:00:00+00:00 https://biolegacyresearch.com/fda-outlines-guidance-for-generic-abuse-deterrent-opioid-pills/ 2017-11-21T23:42:49+00:00 https://biolegacyresearch.com/ema-adopts-guideline-on-developing-treatments-for-autism/ 2017-11-21T23:43:37+00:00 https://biolegacyresearch.com/genentech-sues-pfizer-over-herceptin-biosimilar-patents/ 2017-11-21T23:44:35+00:00 https://biolegacyresearch.com/fda-warns-indiana-compounder-over-unapproved-drugs/ 2017-11-21T23:45:42+00:00 https://biolegacyresearch.com/amerisourcebergen-coughs-up-625m-to-resolve-u-s-government-probe/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/eli-lilly-quietly-works-on-wearable-devices-in-lab-established-in-2015/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/pfizer-and-genentech-duke-it-out-in-court-over-herceptin-biosimilar-patents/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-upstart-takes-on-mighty-purdue-pharma-over-tougher-to-abuse-opioids/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/the-biotech-that-has-almost-doubled-in-2017-with-the-potential-to-boom-even-more/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/canadas-concordia-accused-of-6000-price-increase-for-drug-overcharging-nhs-by-100m-pounds/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithklines-viiv-healthcare-wins-first-fda-ok-for-two-drug-hiv-regimen/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/this-is-what-amazon-can-do-to-start-selling-drugs-faster/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/heptares-founder-shares-her-best-life-sciences-career-advice/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/puma-biotechnology-and-specialised-therapeutics-asia-enter-into-exclusive-licensing-agreement-to/ 2017-11-22T00:00:00+00:00 https://biolegacyresearch.com/emas-new-eudravigilance-system-goes-live/ 2017-11-22T21:30:53+00:00 https://biolegacyresearch.com/judge-rejects-aegerion-plea-deal-for-deceptive-cholesterol-drug-marketing/ 2017-11-22T21:32:45+00:00 https://biolegacyresearch.com/biologics-manufacturers-need-more-adaptable-modular-strategies-tufts-study/ 2017-11-22T21:33:52+00:00 https://biolegacyresearch.com/uk-watchdog-claims-concordia-overcharged-for-generic-thyroid-medication/ 2017-11-22T21:34:36+00:00 https://biolegacyresearch.com/phrma-aam-spar-on-hatch-waxman-provisions/ 2017-11-22T21:40:59+00:00 https://biolegacyresearch.com/qiagen-plans-to-create-up-to-800-jobs-at-new-uk-campus-post-brexit/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/merck-plots-950-job-rd-hub-in-london/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/3-top-diabetes-biotechs-to-buy-into-right-now/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/why-shire-should-spin-off-its-neuroscience-biz-and-merge-with-this-maryland-pharma/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-partners-up-with-chinese-fund-to-launch-new-biopharma-company/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/innate-tanked-as-drug-combined-with-bristol-myers-opdivo-flopped-in-study/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/teva-expected-to-fire-up-to-1700-workers-in-israel-u-s/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/teva-shakes-up-c-suite-in-restructuring/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/biogen-forges-278m-ms-tie-up-with-alkermes/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-medeor-therapeutics-bags-57m/ 2017-11-27T00:00:00+00:00 https://biolegacyresearch.com/supreme-court-divided-on-future-of-the-ptab/ 2017-11-27T22:51:45+00:00 https://biolegacyresearch.com/fda-guidance-details-product-tracing-exemptions-under-the-dscsa/ 2017-11-27T22:52:58+00:00 https://biolegacyresearch.com/judge-denies-new-lawsuit-for-parents-who-claimed-depakote-birth-defects/ 2017-11-27T22:54:04+00:00 https://biolegacyresearch.com/european-commission-issues-new-gmp-guidelines-for-advanced-therapies/ 2017-11-27T22:55:13+00:00 https://biolegacyresearch.com/fda-cites-sterile-drugmaker-over-sanitation-complaints-and-product-discrepancies/ 2017-11-27T22:56:19+00:00 https://biolegacyresearch.com/why-a-buyout-deal-may-not-be-in-the-cards-for-acadia/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/little-known-synthorx-names-former-cleave-ceo-as-new-leader/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/why-the-best-is-yet-to-come-for-this-tiny-massachusetts-biotech/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/these-2-biotechs-just-won-bristol-myers-golden-ticket-award/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/merck-kgaa-pfizers-bavencio-flunks-late-stage-gastric-cancer-trial/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-yanks-plans-for-first-rd-facility-in-the-uk/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-gritstone-oncology-to-ramp-up-hiring-at-new-manufacturing-facility/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/auris-abandons-hearing-loss-drug-after-phase-iii-flop-stock-sinks/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-ardelyx-nabs-160m-deal-with-kyowa-hakko-kirin/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/clovis-expands-bay-area-footprint-with-huge-lease-in-oakland/ 2017-11-28T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-previews-upcoming-guidances-on-complex-generics/ 2017-11-28T22:49:14+00:00 https://biolegacyresearch.com/ema-outlines-methods-for-transferring-product-approvals-before-brexit/ 2017-11-28T22:50:06+00:00 https://biolegacyresearch.com/uk-unveils-plan-for-investment-in-life-sciences/ 2017-11-28T22:50:52+00:00 https://biolegacyresearch.com/oig-medicare-spent-366-million-more-by-including-self-administered-drugs-in-part-b-calculations/ 2017-11-28T22:51:53+00:00 https://biolegacyresearch.com/why-this-overlooked-seattle-drugmaker-could-be-the-best-biotech-buy-right-now/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/meet-the-scientist-who-admits-his-ms-therapy-is-largely-ineffective/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/why-this-small-socal-biotechs-pipeline-makes-it-flushed-for-growth/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/regeneron-forges-out-of-the-box-rd-pact-with-bostons-decibel-therapeutics/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/itus-pushes-car-t-program-for-solid-tumors-develops-early-cancer-detection-platform/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/frazier-backed-mavupharma-scores-20m-to-fund-sting-program/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/alkermes-allegedly-fired-3-female-employees-who-raised-concerns-of-bias/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/boston-scientific-loses-3b-on-latest-lotus-valve-delay/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/struggling-the-medicines-company-deals-its-infectious-disease-biz-to-melinta-for-270m/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/wavelength-pharma-names-former-sun-exec-as-new-ceo/ 2017-11-29T00:00:00+00:00 https://biolegacyresearch.com/trumps-pick-for-hhs-tells-senate-drug-prices-are-too-high/ 2017-11-29T22:38:29+00:00 https://biolegacyresearch.com/pfizer-settles-with-purchasers-for-94-million-over-celebrex-pay-for-delay-deal/ 2017-11-29T22:39:18+00:00 https://biolegacyresearch.com/insurance-trust-fund-sues-allergan-for-anticompetitive-practices/ 2017-11-29T22:40:05+00:00 https://biolegacyresearch.com/korean-firm-draws-fda-warning-for-gmp-violations-mislabeling/ 2017-11-29T22:40:49+00:00 https://biolegacyresearch.com/mettler-toledo-to-begin-layoffs-in-march-69-employees-affected/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/mind-blowing-amgens-aimovig-halves-length-of-migraine-attacks-in-phase-iii-study/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/bayer-head-of-discovery-exits-as-drugmaker-combines-pharma-rd-unit/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/3-big-pharmas-that-could-be-winners-for-investors-in-the-long-run/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/cambridges-semma-therapeutics-lands-114m-for-novel-diabetes-quest/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/genmab-and-johnson-johnson-rake-in-the-bucks-together-sparking-takeover-speculation/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/sanofi-takes-a-120m-hit-as-potential-dengue-vaccine-blockbuster-dealt-safety-blow/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/bostons-anti-aging-startup-restorbio-scores-40m/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/sexual-harassment-scandals-hit-novartis-and-pfizers-korea-units/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/3-bioeconomy-stocks-investors-should-not-hesitate-to-buy/ 2017-11-30T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-provides-update-one-year-after-the-cures-act/ 2017-11-30T22:51:14+00:00 https://biolegacyresearch.com/dr-reddys-hit-with-class-action-suit-claiming-false-statements/ 2017-11-30T22:53:21+00:00 https://biolegacyresearch.com/texas-compounder-warned-for-sterility-practices-other-gmp-violations/ 2017-11-30T22:54:48+00:00 https://biolegacyresearch.com/basilea-snags-extended-226m-antifungal-deal-with-pfizer/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/why-bristol-myers-future-is-highly-dependent-on-these-2-cancer-drugs/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/astellas-takes-out-massachusetts-biotech-mitobridge-in-390m-deal/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/bayers-former-head-of-discovery-lands-new-cso-gig-at-shire/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/why-this-bay-area-heart-software-biotech-could-become-silicon-valleys-newest-unicorn/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/foundation-medicine-wins-approval-from-the-fda-and-medicare-for-first-of-its-kind-cancer-test/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/why-this-6-employee-biotechs-stock-jumped-2000-in-just-three-days/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/higher-death-rate-forces-bayer-to-stop-xofigozytiga-combo-late-stage-study-early/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-to-load-up-on-this-holiday-season/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/amazon-in-exploratory-talks-with-mylan-novartis-about-pharma-entry/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/active-biotechs-laquinimod-fails-to-meet-primary-endpoint-in-phase-ii-trial/ 2017-12-01T00:00:00+00:00 https://biolegacyresearch.com/fda-approves-monthly-buprenorphine-mat-for-opioid-use-disorder/ 2017-12-01T22:19:01+00:00 https://biolegacyresearch.com/fda-expects-iv-saline-shortage-to-improve-by-years-end-shifts-focus-to-amino-acids/ 2017-12-01T22:19:49+00:00 https://biolegacyresearch.com/ema-updates-brexit-guidance-with-info-for-generics-manufacturers/ 2017-12-01T22:20:41+00:00 https://biolegacyresearch.com/emas-prac-revises-methods-for-measuring-pharmacovigilance-impacts/ 2017-12-01T22:21:34+00:00 https://biolegacyresearch.com/4-solid-biotechs-to-load-up-on-this-month/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/sanofis-bad-end-of-the-year-continues-with-axing-of-its-c-diff-drug/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-investors-rejoice-after-copd-drug-performs-in-phase-iv-study/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/the-philippines-suspends-sanofis-dengue-vaccine-after-730000-children-are-immunized/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/amgen-on-a-roll-as-the-fda-oks-repatha-to-prevent-heart-attack-and-stroke/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/2-bay-area-biotechs-expected-to-grow-67-or-up-over-the-next-five-years/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/little-idorsia-scores-230m-rd-deal-with-johnson-johnson/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/longtime-seattle-genetics-coo-jumps-ship-to-helm-biotech-startup-silverback-therapeutics/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/gilead-commits-100m-to-tackle-the-hivaids-epidemic-in-the-southern-u-s/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/ultragenyx-stock-booms-after-burosumab-continues-to-impress-in-phase-iii-study/ 2017-12-04T00:00:00+00:00 https://biolegacyresearch.com/phrma-says-many-drug-price-discounts-dont-reach-patients/ 2017-12-04T22:37:44+00:00 https://biolegacyresearch.com/fda-expands-october-anda-numbers-with-first-cycle-approval-totals/ 2017-12-04T22:38:38+00:00 https://biolegacyresearch.com/drugmakers-call-on-fda-to-clarify-biosimilar-statistical-approaches-guidance/ 2017-12-04T22:39:36+00:00 https://biolegacyresearch.com/eea-third-country-gmp-inspections-drop-by-25-percent-in-2016/ 2017-12-04T22:40:35+00:00 https://biolegacyresearch.com/79-employees-affected-as-novartis-plans-shut-down-of-uk-site/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/galectin-tanks-as-nash-drug-flunks-phase-iib-trial/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/meet-the-5-scientists-who-just-won-silicon-valley-billionaires-breakthrough-prize/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/fortress-biotech-forms-subsidiary-tamid-bio-to-develop-novel-aav-gene-therapies-in-orphan-disease/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/1-year-old-biotech-startup-lifeomic-to-create-225-jobs-at-new-hq/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/why-pfizer-could-and-should-scoop-up-celgene-in-2018/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/ra-pharma-crashed-as-certain-patients-failed-to-tolerate-switch-from-alexions-soliris/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/lexicon-pharma-secures-up-to-200m-non-dilutive-term-loan-financing/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/3-biotech-stocks-that-exploded-in-2017/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/europes-neurosearch-exploring-sale-possible-liquidation-of-company-in-the-next-few-months/ 2017-12-05T00:00:00+00:00 https://biolegacyresearch.com/international-drugmakers-plan-for-more-manufacturing-testing-costs-as-brexit-looms/ 2017-12-05T22:46:27+00:00 https://biolegacyresearch.com/fda-breakthrough-designations-can-knock-off-three-years-of-development-study-finds/ 2017-12-05T22:47:44+00:00 https://biolegacyresearch.com/sanofi-and-jj-rank-highest-in-clinical-trial-transparency-study/ 2017-12-05T22:49:05+00:00 https://biolegacyresearch.com/judge-allows-suit-against-compounder-for-overcharging-tricare-to-go-ahead/ 2017-12-05T22:50:18+00:00 https://biolegacyresearch.com/1-year-old-biotech-goldfinch-steals-astrazeneca-rd-exec-for-ceo-post/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/cambridge-biotech-obsidian-launches-with-49-5m-investment-from-google-takeda-vertex-amgen-and/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/ex-employees-accuse-biotech-hedge-fund-founder-of-toxic-sexual-harassment-culture/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/uk-science-gets-more-post-brexit-love-from-glaxosmithkline-other-drugmakers/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/4-biotechs-facing-do-or-die-catalysts-in-december/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/san-diegos-vital-therapies-names-ex-jazz-pharma-exec-as-new-chief-leader/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/investigation-leads-socals-avanir-to-quietly-lay-off-73-employees/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/how-cambridge-biotech-akcea-teaches-its-80-employees-to-put-a-human-face-on-illnesses/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-carmot-lands-240m-rd-tie-up-with-biotech-giant-amgen/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/amazon-yanks-pharma-license-app-in-maine/ 2017-12-06T00:00:00+00:00 https://biolegacyresearch.com/fda-considers-vicarious-criminal-liability-for-senior-company-officials/ 2017-12-06T23:16:31+00:00 https://biolegacyresearch.com/fda-proposes-collaborative-approach-for-pediatric-rare-disease-research/ 2017-12-06T23:17:49+00:00 https://biolegacyresearch.com/jury-orders-bayer-jj-to-pay-28-million-for-xarelto-claims-in-first-bellwether-loss/ 2017-12-06T23:19:21+00:00 https://biolegacyresearch.com/ptab-judge-issues-guidance-on-amending-patents-following-circuit-court-decision/ 2017-12-06T23:20:28+00:00 https://biolegacyresearch.com/janssens-remicade-biosimilar-infringement-case-against-samsung-bioepis-dismissed/ 2017-12-06T23:21:33+00:00 https://biolegacyresearch.com/pfizer-denies-fumes-from-viagra-factory-are-arousing-irish-towns-males/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/unwanted-light-shines-on-astrazeneca-and-its-blockbuster-seroquel/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/spark-pfizers-gene-therapy-hemophilia-b-drug-stuns-in-trial/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/cambridges-neon-therapeutics-completes-106m-crossover-series-b-funding-round/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/san-diegos-halozyme-lands-potential-680m-rd-deal-with-alexion/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/2018-hiring-trends-for-life-science-job-hunters/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/genentechs-tecentriq-avastin-chemo-combo-dazzles-in-late-stage-study/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-xoma-snags-240m-deal-with-newly-transformed-rezolute/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/nephron-pharma-to-create-125-new-jobs-in-expansion/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/5-smaller-biotechs-that-are-flying-under-the-radar/ 2017-12-07T00:00:00+00:00 https://biolegacyresearch.com/ex-genentech-employees-denali-breaks-2017-ipo-records-raises-250m/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/swedens-active-biotech-is-strapped-for-cash-and-may-not-survive-2018/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/mysterious-nubiyota-inks-lease-for-former-pfizer-campus/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/erytechs-lead-aml-drug-flunks-phase-ii-test/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/fully-loaded-with-nearly-500-employees-in-rockville-glaxosmithkline-chief-lays-out-2018-goals/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/aquinox-statement-on-fda-advisory-committee-meeting-to-discuss-interstitial-cystitisbladder-pain/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/sparks-good-week-continues-with-signing-of-huge-lease-near-hq/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/pfizer-shows-off-phase-iii-breast-cancer-data/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/biotech-hedge-fund-titan-isaly-steps-down-amid-sexual-harassment-claims/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/thrombogenics-struggles-to-find-patients-for-phase-ii-eye-disease-trial/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/steadymed-announces-fda-agreed-pathway-to-trevyent-nda-resubmission/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/aeterna-zentaris-interim-cfo-departs-effective-immediately/ 2017-12-08T00:00:00+00:00 https://biolegacyresearch.com/fda-planning-disease-specific-guidances-and-endpoints-for-new-gene-therapies/ 2017-12-08T00:03:35+00:00 https://biolegacyresearch.com/fda-committee-votes-to-combine-bladder-pain-interstitial-cystitis-patients-in-trials/ 2017-12-08T00:04:39+00:00 https://biolegacyresearch.com/bts-research-passed-usda-inspection/ 2017-12-08T20:10:09+00:00 https://biolegacyresearch.com/cms-prescription-drug-spending-growth-plummeted-to-1-3-percent-in-2016/ 2017-12-09T00:42:00+00:00 https://biolegacyresearch.com/fda-most-sponsors-pmrs-on-time-but-reporting-lags-behind/ 2017-12-09T00:43:00+00:00 https://biolegacyresearch.com/mylan-urges-fda-not-to-approve-advair-generics-based-on-multi-batch-studies/ 2017-12-09T00:44:55+00:00 https://biolegacyresearch.com/payers-providers-want-more-data-from-biopharma-companies/ 2017-12-09T00:45:53+00:00 https://biolegacyresearch.com/debt-ridden-teva-considers-cutting-up-to-10000-jobs/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/genentechs-lymphoma-drug-combo-wows-in-mid-stage-trial/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/merck-laying-off-50-employees-in-north-carolina/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/mako-medical-to-create-153-jobs-in-north-carolina-expansion/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/genentechs-hemlibra-data-continues-to-wow-at-ash/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/janssen-to-terminate-simeprevir-license-with-medivir-effective-june-2018/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-with-critical-product-launches-in-2018/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/top-5-massachusetts-biotechs-that-jumped-at-least-250-in-2017/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/seattles-phaserx-files-for-bankruptcy-as-it-considers-partner-merger-or-sale-options/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/lillys-cyramza-fails-to-improve-overall-survival-in-phase-iii-gastric-cancer-study/ 2017-12-11T00:00:00+00:00 https://biolegacyresearch.com/ema-publishes-qa-on-periodic-safety-update-reports/ 2017-12-11T19:33:01+00:00 https://biolegacyresearch.com/fda-details-product-tracing-exemptions-under-the-dscsa/ 2017-12-11T19:36:16+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-flags-labeling-sterility-other-violations/ 2017-12-11T19:38:54+00:00 https://biolegacyresearch.com/morrison-says-ora-reorganization-will-mean-more-foreign-inspections/ 2017-12-11T19:40:57+00:00 https://biolegacyresearch.com/eea-third-country-gmp-inspections-drops-in-2016/ 2017-12-11T19:42:24+00:00 https://biolegacyresearch.com/483-roundup-three-firms-cited-for-labeling-complaints-safety-problems/ 2017-12-11T19:43:29+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-on-product-name-placement-in-advertisements/ 2017-12-11T23:38:47+00:00 https://biolegacyresearch.com/phrma-sues-california-to-block-law-requiring-advanced-notice-of-price-hikes/ 2017-12-11T23:40:00+00:00 https://biolegacyresearch.com/fdas-complete-responses-to-generic-drugmakers-continue-to-outpace-fiscal-2017/ 2017-12-11T23:41:22+00:00 https://biolegacyresearch.com/fda-hits-glenmark-for-quality-controls-complaint-handling/ 2017-12-11T23:42:46+00:00 https://biolegacyresearch.com/4-possible-biotech-takeover-targets-for-2018/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-aduro-biotech-throws-in-the-towel-on-crs-207-will-wind-down-trials/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithklines-nucala-wins-fda-approval-for-egpa/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/tax-reform-a-war-on-life-sciences-innovation/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/71-of-all-patients-achieved-complete-tumor-remission-on-gilead-kites-car-t-therapy/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/allergan-swoops-in-and-bags-troubled-repros-therapeutics/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/achaogen-coo-promoted-to-top-post-effective-jan-1-2018/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/sanofi-investors-crave-for-a-large-acquisition-drug-news/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/fda-approves-sanofis-admelog-the-first-follow-on-insulin-to-control-sugar-at-mealtime/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/why-this-massachusetts-synthetic-bio-startup-could-be-the-next-biotech-unicorn/ 2017-12-12T00:00:00+00:00 https://biolegacyresearch.com/senate-committee-explores-value-based-drug-pricing-to-help-stem-increases/ 2017-12-12T23:28:49+00:00 https://biolegacyresearch.com/fda-spells-out-refusal-to-file-scenarios-for-ndas-and-blas/ 2017-12-12T23:29:55+00:00 https://biolegacyresearch.com/whistleblower-says-drugmaker-fired-him-for-raising-concerns-about-cmo/ 2017-12-12T23:31:04+00:00 https://biolegacyresearch.com/ansm-creates-new-unit-to-handle-early-stage-clinical-trials/ 2017-12-12T23:31:59+00:00 https://biolegacyresearch.com/korean-manufacturer-warned-for-gmp-quality-violations/ 2017-12-12T23:33:09+00:00 https://biolegacyresearch.com/harpoon-medicals-16-employee-office-will-stay-intact-after-edwards-lifesciences-100m-acquisition/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-pionyr-immunotherapeutics-scores-62m-to-push-anti-tumor-tech-towards-clinic/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/how-glycomimetics-defied-a-hematology-biotech-pitfall-while-its-peers-fell/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/jj-sanofi-top-bioethics-international-transparency-report/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/gw-pharma-otsuka-satvex-deal-terminated/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/daichi-sankyo-abandons-deal-with-nektar-therapeutics-after-drug-tanks-in-europe/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/roche-gets-in-on-bay-area-allakos-100m-funding-round/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/why-bluebird-bio-investors-arent-singing-the-blues/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/why-pfizers-2017-was-mediocre-at-best/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/besties-regeneron-sanofi-show-off-phase-ii-skin-cancer-data/ 2017-12-13T00:00:00+00:00 https://biolegacyresearch.com/house-panel-polls-pharmaceutical-sector-on-reasons-for-high-drug-prices/ 2017-12-13T23:13:46+00:00 https://biolegacyresearch.com/phrma-unveils-multi-million-dollar-initiative-on-opioid-addiction/ 2017-12-13T23:14:53+00:00 https://biolegacyresearch.com/circuit-court-upholds-ptab-ruling-invalidating-daiichi-sankyo-patents/ 2017-12-13T23:16:18+00:00 https://biolegacyresearch.com/new-jersey-drugmaker-draws-fda-warning-for-adulteration/ 2017-12-13T23:17:30+00:00 https://biolegacyresearch.com/argenx-bags-231m-in-upsized-u-s-ipo/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/grail-poaches-new-ceo-from-roche-genentech/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/this-is-the-drug-that-could-kick-regenerons-stock-into-gear/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/the-next-biotech-unicorn-ginkgo-bioworks-just-nabbed-another-275m/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/takeda-takes-stake-inks-deal-with-newly-launched-izana-bioscience/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/little-remynd-forges-350m-euros-tie-up-with-drug-giant-novo-nordisk/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/another-biotech-bites-the-dust-as-cambridges-raze-shuts-down/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/relay-therapeutics-lands-63m-to-push-its-cancer-candidates-into-clinic/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-forks-over-40m-upfront-for-another-one-of-ono-pharmas-cancer-prospects/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/kyn-therapeutics-banks-49m-to-advance-cancer-immunometabolism-therapies/ 2017-12-14T00:00:00+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-on-direct-marking-requirements-for-udis/ 2017-12-14T20:40:52+00:00 https://biolegacyresearch.com/fda-details-initial-thoughts-on-3d-printed-medical-devices/ 2017-12-14T20:51:33+00:00 https://biolegacyresearch.com/devicemakers-support-tgas-approach-to-beefing-up-sanctions-penalties/ 2017-12-14T20:52:52+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-to-limit-exposure-with-x-ray-imaging/ 2017-12-14T20:56:00+00:00 https://biolegacyresearch.com/fda-plans-to-regulate-genetic-health-tests-as-class-ii-devices/ 2017-12-14T20:57:12+00:00 https://biolegacyresearch.com/fda-adds-contraindication-to-labeling-of-ultrasonic-aspirators/ 2017-12-14T20:58:38+00:00 https://biolegacyresearch.com/warning-letter-roundup-four-firms-draw-warnings-for-noncompliance/ 2017-12-14T20:59:00+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-firms-over-mdrs-capas-history-records/ 2017-12-14T21:00:55+00:00 https://biolegacyresearch.com/boehringer-cfo-quits-after-16-months-on-the-job-over-differences-in-strategy/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/mercks-ace-keytruda-flunks-key-phase-iii-stomach-cancer-study/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/biotechs-drool-as-vc-firm-andreessen-horowitz-doubles-down-on-the-life-sciences-with-new-450m-fund/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/asklepios-biopharma-launches-new-biotech-actus-therapeutics/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/suitors-line-up-for-merck-kgaas-4-7b-consumer-health-biz/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/pfizer-announces-fda-approval-of-xeljanz-tofacitinib-and-xeljanz-xr-for-the-treatment-of-active/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/these-2-startups-are-amgens-2017-golden-ticket-winners/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/novartis-oncology-head-to-retire-for-personal-reasons/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/in-the-nick-of-time-galapagos-nabs-co-promotion-filgotinib-deal-with-gilead/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/bay-area-rigels-cfo-to-exit-effective-dec-31-2017/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/finally-some-good-news-as-the-fda-lifts-hold-on-sanofi-alnylams-fitusiran/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/how-amicus-ceo-personally-appealed-to-fda-head-to-get-migalastat-back-on-track/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/why-abbvies-booming-2017-could-continue-in-2018/ 2017-12-15T00:00:00+00:00 https://biolegacyresearch.com/drugmakers-call-for-more-flexible-templates-for-rems/ 2017-12-15T00:43:04+00:00 https://biolegacyresearch.com/suits-allege-amgen-bayer-and-gilead-paid-nurses-to-hype-drugs/ 2017-12-15T00:43:53+00:00 https://biolegacyresearch.com/court-axes-lawsuit-claiming-insufficient-warning-of-heart-attack-risk-from-gsk-drug/ 2017-12-15T00:44:50+00:00 https://biolegacyresearch.com/gottlieb-fda-to-expand-non-prescription-access-to-drugs-in-2018/ 2017-12-15T22:22:54+00:00 https://biolegacyresearch.com/fda-draft-guidance-covers-new-discipline-review-letters-added-by-gdufa-ii/ 2017-12-15T22:23:36+00:00 https://biolegacyresearch.com/fda-offers-guidance-on-targeting-rare-molecular-subsets-of-diseases/ 2017-12-15T22:24:33+00:00 https://biolegacyresearch.com/fda-issues-draft-guidance-on-nanomaterial-drug-development/ 2017-12-15T22:25:35+00:00 https://biolegacyresearch.com/emas-chmp-recommends-seven-medicines-for-approval-including-one-cell-therapy/ 2017-12-15T22:26:26+00:00 https://biolegacyresearch.com/gilead-could-acquire-galapagos-within-weeks/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/worlds-top-5-best-selling-drugs-in-2017/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/chiome-bioscience-chugai-pharma-terminate-partnership/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/8-possible-biopharma-takeover-targets-for-2018/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/intellia-therapeutics-gets-new-chief/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/boehringer-inks-e627-5m-deal-with-glaxosmithkline-spinout/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/12-clinical-successes-of-2017/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/neurotrope-poaches-forest-lab-exec-to-be-ceo/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/aptinyx-bags-70m-financing-to-fuel-expanding-pipeline/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/novartis-buys-rare-drug-voucher-for-130m-from-ultragenyx/ 2017-12-18T00:00:00+00:00 https://biolegacyresearch.com/fda-updates-generics-comms-guidance-for-gdufa-ii/ 2017-12-18T15:30:00+00:00 https://biolegacyresearch.com/ftc-number-of-pay-for-delay-settlements-continues-to-drop/ 2017-12-18T15:30:00+00:00 https://biolegacyresearch.com/fda-takes-aim-at-delaying-tactics-for-shared-rems/ 2017-12-18T15:30:00+00:00 https://biolegacyresearch.com/jj-sued-for-blocking-biosimilar-remicade-competition/ 2017-12-18T15:30:00+00:00 https://biolegacyresearch.com/uk-watchdog-claims-concordia-overcharged-for-thyroid-generic/ 2017-12-18T15:30:00+00:00 https://biolegacyresearch.com/cber-urges-sponsors-to-adopt-international-standards/ 2017-12-18T23:05:38+00:00 https://biolegacyresearch.com/ema-adopts-ich-guideline-on-multi-region-clinical-trials/ 2017-12-18T23:06:00+00:00 https://biolegacyresearch.com/experts-weigh-in-at-fda-meeting-on-patient-centric-drug-development/ 2017-12-18T23:08:52+00:00 https://biolegacyresearch.com/apotex-facility-in-india-flagged-for-gmp-non-compliance/ 2017-12-18T23:11:24+00:00 https://biolegacyresearch.com/spark-gets-fda-greenlight-for-luxturna-the-first-gene-therapy-for-eye-disease-approved-in-the-u-s/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/shires-hunter-syndrome-treatment-failed-phase-iiiii-goals/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/roche-shire-patent-fight-escalates-over-haemophilia-drug/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/with-a-collaboration-deal-in-place-with-merck-cue-biopharma-plans-60-million-ipo/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/boehringer-ingelheim-roche-forge-partnership-for-inflammatory-bowel-diseases/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/bay-area-biotech-forges-multi-year-research-deal-with-genentech/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/billionaire-george-soros-bets-big-against-2-struggling-drugmakers-but-one-could-make-a-big-come/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/roche-boss-claims-pred-division-soon-to-emerge-from-genentechs-shadow/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/pfizer-strikes-deal-with-array-biopharma-on-anti-cancer-development/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/bay-area-bigfoot-biomedical-bags-37m-series-b-financing/ 2017-12-19T00:00:00+00:00 https://biolegacyresearch.com/viagra-to-be-available-over-the-counter-in-the-uk-next-year/ 2017-12-19T20:31:44+00:00 https://biolegacyresearch.com/igdrp-issues-guidance-for-quality-assessment-reports/ 2017-12-19T20:36:32+00:00 https://biolegacyresearch.com/ema-adopts-guideline-on-treatments-for-autism/ 2017-12-19T20:37:35+00:00 https://biolegacyresearch.com/tufts-biologics-manufacturers-need-more-adaptable-strategies/ 2017-12-19T20:39:32+00:00 https://biolegacyresearch.com/uk-watchdog-claims-concordia-overcharged-for-thyroid-meds/ 2017-12-19T20:40:28+00:00 https://biolegacyresearch.com/fda-approves-gene-therapy-for-retinal-dystrophy/ 2017-12-19T23:04:51+00:00 https://biolegacyresearch.com/fda-closes-orphan-designation-loophole-for-pediatric-subpopulations/ 2017-12-19T23:06:26+00:00 https://biolegacyresearch.com/house-cuts-orphan-drug-credit-in-half-as-part-of-tax-reform-bill/ 2017-12-19T23:07:37+00:00 https://biolegacyresearch.com/gao-reports-on-drug-pricing-rd-changes/ 2017-12-19T23:08:26+00:00 https://biolegacyresearch.com/fda-unveils-risk-based-enforcement-approach-to-homeopathic-drugs/ 2017-12-19T23:09:26+00:00 https://biolegacyresearch.com/bay-area-biotech-forges-exclusive-pact-with-zai-lab-for-gastric-cancer-drug-development/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/13-employee-socal-startup-bioniz-has-a-400-million-valuation/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/flagship-pioneering-secures-618m-for-life-science-startup-mission/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/3-hottest-areas-of-drug-development-to-keep-an-eye-on-in-2018/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/why-this-little-known-biotech-is-pharmas-new-poster-child-for-price-gouging/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/abbvie-scores-key-trial-win-for-ra-drug-with-one-fatal-event-reported/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/millendo-therapeutics-sweeps-up-phase-ii-asset-with-acquisition-of-small-biotech/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/jsr-life-sciences-snaps-up-cro-in-400m-deal/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/juno-thermo-fisher-ink-car-t-manufacturing-partnership/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/orchard-therapeutics-scoops-up-110m-in-funding-to-advance-bubble-boy-syndrome-gene-therapy/ 2017-12-20T00:00:00+00:00 https://biolegacyresearch.com/french-authority-fines-jj-e25-million-for-blocking-generics/ 2017-12-20T23:18:58+00:00 https://biolegacyresearch.com/ptab-begins-ipr-review-of-two-sanofi-patents/ 2017-12-20T23:20:28+00:00 https://biolegacyresearch.com/fda-updates-1997-guidance-on-cmc-changes-for-approved-biologics/ 2017-12-21T22:06:34+00:00 https://biolegacyresearch.com/fda-removes-boxed-warning-from-labaics-inhalers-following-postmarket-studies/ 2017-12-21T22:07:32+00:00 https://biolegacyresearch.com/boehringer-to-pay-13-5-million-settlement-for-improper-off-label-promotion/ 2017-12-21T22:08:24+00:00 https://biolegacyresearch.com/janssen-forges-global-pact-with-legend-biotech-to-develop-investigational-car-t-anti-cancer-therapy/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/celgene-crashed-after-follicular-lymphoma-regimen-failed-phase-iii/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/north-carolina-sues-insys-accused-of-bribing-doctors-to-prescribe-powerful-opioid-spray/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/9-reasons-to-buy-pfizer-in-2018-and-1-big-one-not-to/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/biocons-biosimilar-arm-may-raise-500m-to-fund-clinical-development/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/teva-sees-approval-at-finish-line-for-anti-cgrp-migraine-treatment/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/arno-therapeutics-is-shuttering-its-doors/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/3-hot-cancer-immunotherapies-waiting-to-blast-off-in-2018/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/3-marijuana-biotech-stock-winners-for-2018/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/fda-rejects-agiles-contraceptive-patch-twirla-for-a-second-time/ 2017-12-22T00:00:00+00:00 https://biolegacyresearch.com/data-integrity-will-be-fdas-focus-for-quality/ 2017-12-25T20:38:00+00:00 https://biolegacyresearch.com/experts-see-use-of-real-world-evidence-as-a-key-clinical-trial-trend/ 2017-12-25T20:39:00+00:00 https://biolegacyresearch.com/fda-plans-to-expedite-product-reviews-by-hiring-more-staff/ 2017-12-25T20:40:00+00:00 https://biolegacyresearch.com/ema-juggling-brexit-and-new-quality-and-safety-guidelines-for-2018/ 2017-12-25T20:41:00+00:00 https://biolegacyresearch.com/whats-ahead-for-2018/ 2017-12-25T21:29:00+00:00 https://biolegacyresearch.com/fda-targets-generic-approvals-drug-pricing-for-2018/ 2017-12-25T21:30:00+00:00 https://biolegacyresearch.com/senators-seek-clarity-on-fdas-canadian-drug-importation-policy/ 2017-12-26T22:13:00+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-on-biowaivers-and-biopharmaceutical-classification/ 2017-12-26T22:14:00+00:00 https://biolegacyresearch.com/fda-reminds-sponsors-to-submit-one-time-orange-book-status-report/ 2017-12-26T22:15:00+00:00 https://biolegacyresearch.com/novartis-can-be-sued-for-damage-caused-by-generics-california-court-rules/ 2017-12-26T22:16:00+00:00 https://biolegacyresearch.com/united-therapeutics-settles-federal-kickback-lawsuit-for-210-million/ 2017-12-26T22:16:00+00:00 https://biolegacyresearch.com/reckitt-ceos-17b-predicament/ 2017-12-27T00:00:00+00:00 https://biolegacyresearch.com/how-this-crispr-biotech-could-make-investors-rich/ 2017-12-27T00:00:00+00:00 https://biolegacyresearch.com/array-biopharma-spun-off-heart-drug-rd-into-new-subsidiary-yarra-therapeutics/ 2017-12-27T00:00:00+00:00 https://biolegacyresearch.com/the-number-1-small-cap-biotech-investors-are-missing-out-on/ 2017-12-27T00:00:00+00:00 https://biolegacyresearch.com/mallinckrodt-takes-out-sucampo-in-surprising-1-2b-deal/ 2017-12-27T00:00:00+00:00 https://biolegacyresearch.com/marylands-precision-medicine-group-lands-275m/ 2017-12-27T00:00:00+00:00 https://biolegacyresearch.com/socals-peregrine-names-a-new-ceo-to-change-name-to-avid-bioservices/ 2017-12-27T00:00:00+00:00 https://biolegacyresearch.com/shire-plans-to-hire-in-2018-for-its-georgia-manufacturing-site/ 2017-12-27T00:00:00+00:00 https://biolegacyresearch.com/novartis-tasigna-wins-fda-nod-for-first-and-only-cml-therapy-with-treatment-free-remission-data/ 2017-12-27T00:00:00+00:00 https://biolegacyresearch.com/fda-issues-new-class-warning-requirements-for-gadolinium-contrast-agents/ 2017-12-27T22:00:00+00:00 https://biolegacyresearch.com/quality-system-deficiencies-dominate-mhras-gdp-deficiency-report/ 2017-12-27T22:00:00+00:00 https://biolegacyresearch.com/canadian-drugmaker-warned-for-sterility-verification-procedural-issues/ 2017-12-27T22:00:00+00:00 https://biolegacyresearch.com/fda-flags-impax-laboratories-for-equipment-problem/ 2017-12-27T22:00:00+00:00 https://biolegacyresearch.com/ptab-says-sovereign-immunity-traded-away-by-filing-infringement-suits-in-court/ 2017-12-27T22:00:00+00:00 https://biolegacyresearch.com/pharma-bro-shkrelis-ex-lawyer-convicted-of-helping-him-defraud-pharma-firm/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/5-biotechs-awaiting-fda-decisions-in-january-2018/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/2-small-cap-biotechs-bestie-celgene-is-cutting-back-on/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/fda-accepts-gw-pharmas-epidiolex-nda-with-priority-review-for-lennox-gastaut-syndrome-and-dravet/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/4-top-performing-sp-500-biotech-stocks-of-2017/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/keryx-norwich-pharma-mutually-terminate-manufacturing-agreement/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/fresenius-se-allegedly-ignored-hundreds-of-bad-quality-tests-at-plant-in-india/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/shareholders-turn-down-tender-offer-to-take-biocancell-private/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/china-focused-life-science-investor-acquires-37-of-novabay-for-28m/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/doctors-accuse-nextsource-biotech-for-hiking-the-price-on-key-cancer-drug-nine-times/ 2017-12-28T00:00:00+00:00 https://biolegacyresearch.com/fda-to-commit-to-faster-end-of-phase-meetings-in-guidance-to-developers/ 2017-12-28T22:55:24+00:00 https://biolegacyresearch.com/senators-call-on-dea-for-guidance-on-partial-fill-of-opioid-prescriptions/ 2017-12-28T22:56:24+00:00 https://biolegacyresearch.com/kmart-to-settle-fca-violation-allegations-for-32-2-million/ 2017-12-28T22:57:08+00:00 https://biolegacyresearch.com/bay-areas-menlo-therapeutics-files-for-98m-ipo/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-unloads-four-ndas-to-ani-pharmaceuticals-in-46-5m-deal/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/4-biotechs-ready-to-kill-the-market-in-2018/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/shanghais-sari-pays-359m-for-italian-cancer-biopharma-nms/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/the-numbers-are-in-bay-areas-depomed-reveals-328-job-cuts-in-warn-notice/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/celgene-takes-a-411m-hit-from-discontinuation-of-crohns-disease-trials/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/investors-irate-as-j-p-morgan-bars-press-from-biggest-biotech-conference-of-the-year/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/why-investors-should-dodge-gilead-in-2018/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnsons-potential-depression-blockbuster-esketamine-shows-promise-in-phase-ii-study/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/chugai-commits-220m-into-singapore-drug-lab/ 2017-12-29T00:00:00+00:00 https://biolegacyresearch.com/fda-outlines-combination-contraceptive-labeling-in-new-draft-guidance/ 2018-01-01T21:13:00+00:00 https://biolegacyresearch.com/dea-proposes-to-place-fentanyl-products-in-schedule-i/ 2018-01-01T21:14:00+00:00 https://biolegacyresearch.com/clinicaltrials-gov-receives-new-update-allowing-better-geographic-searches/ 2018-01-01T21:15:00+00:00 https://biolegacyresearch.com/new-jersey-firm-warned-for-quality-deficiencies/ 2018-01-01T21:16:00+00:00 https://biolegacyresearch.com/fda-cites-indian-drugmaker-for-sterility-testing-issues/ 2018-01-01T21:17:00+00:00 https://biolegacyresearch.com/celgene-co-founder-bags-23m-for-johns-hopkins-spinout-neximmune/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/top-20-life-science-startups-to-watch-in-2018/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-selecta-biosciences-ceo-to-retire-at-the-end-of-2018/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/5-massachusetts-biotechs-that-tanked-more-than-60-in-2017/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-dnanexus-scores-58m-to-accelerate-expansion/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/2-underappreciated-biotech-stocks-to-buy-in-2018/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/former-pfizer-ceos-boston-startup-centrexion-lands-67m-for-ph3-osteoarthritis-pain-drug/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-seeking-271m-ipo-in-the-new-year/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/optinose-gets-100m-debt-financing-from-athyrium-capital-management/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/arrogance-and-greed-ackman-valeant-pay-290m-to-end-allergan-insider-trading-lawsuit/ 2018-01-02T00:00:00+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-trial-design-for-hypogonadism-drugs/ 2018-01-02T23:16:11+00:00 https://biolegacyresearch.com/judge-tosses-inconsistent-abbvie-bellwether-verdict-orders-new-trial/ 2018-01-02T23:22:47+00:00 https://biolegacyresearch.com/fda-novel-drug-approvals-spiked-last-year/ 2018-01-02T23:24:12+00:00 https://biolegacyresearch.com/tga-issues-new-criteria-for-comparable-overseas-regulators/ 2018-01-02T23:27:13+00:00 https://biolegacyresearch.com/korean-manufacturer-warned-for-adulterated-products/ 2018-01-02T23:29:03+00:00 https://biolegacyresearch.com/sparks-blindness-curing-gene-therapy-comes-with-a-850000-price-tag/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/fda-hails-novartis-kisqali-a-breakthrough/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/addex-indivior-forge-335m-addiction-disorder-tie-up/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/nyc-startup-syntimmune-names-former-biogen-exec-as-new-ceo/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/san-diegos-denovo-biopharma-opens-doors-to-new-rd-center-names-new-cmo-and-cfo/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-bluerock-therapeutics/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/new-socal-biotech-launches-with-55-3m-backed-by-novartis-sanofi-and-5am-ventures/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/drum-roll-pleaseintroducing-the-2018-life-sciences-hotbeds/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/biotech-startup-elstar-therapeutics-closes-39m-for-new-immunotherapy-approach/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/sangamo-pfizer-deepen-relationship-with-new-162m-als-rd-pact/ 2018-01-03T00:00:00+00:00 https://biolegacyresearch.com/fda-issues-draft-guidance-updates-staff-manual-to-speed-anda-reviews/ 2018-01-03T23:29:49+00:00 https://biolegacyresearch.com/doj-recovered-900-million-from-fca-violators-in-pharma-last-year/ 2018-01-03T23:30:58+00:00 https://biolegacyresearch.com/spark-therapeutics-proposes-value-based-reimbursement-installment-plans-for-luxturna/ 2018-01-03T23:31:55+00:00 https://biolegacyresearch.com/retirement-funds-sue-valeant-for-billions-lost-through-price-gouging-scheme/ 2018-01-03T23:32:56+00:00 https://biolegacyresearch.com/indian-facility-warned-for-repeat-sterility-concerns/ 2018-01-03T23:33:53+00:00 https://biolegacyresearch.com/bay-areas-chemocentryx-gets-up-to-100m-in-new-capital-commitments/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/stoke-therapeutics-comes-out-of-seed-mode-with-40m-and-ex-sarepta-ceo-at-its-helm/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/triumvira-names-a-new-ceo/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-prelude-fertility/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/german-biotech-biontech-locks-in-270m-series-a/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/pfizer-arvinas-forge-830m-protein-degradation-rd-deal/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/ovascience-pinks-slips-nearly-50-of-workforce/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/neurogastrx-bags-45m-a-new-ceo-and-a-hq-move-to-the-greater-boston-area/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/generation-bio-emerges-with-25m-and-former-sobi-ceo-as-its-new-leader/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/novartis-new-year-continues-with-second-fda-breakthrough-tag-of-the-week/ 2018-01-04T00:00:00+00:00 https://biolegacyresearch.com/opdp-enforcement-letters-in-2017-hit-record-low/ 2018-01-04T22:45:46+00:00 https://biolegacyresearch.com/saint-regis-tribe-seeks-information-on-ptab-panel/ 2018-01-04T22:46:46+00:00 https://biolegacyresearch.com/fda-denies-allergan-petition-for-higher-bar-for-restasis-copies/ 2018-01-04T22:47:33+00:00 https://biolegacyresearch.com/teva-union-reach-deal-on-hq-layoffs-for-administrative-staff/ 2018-01-05T00:00:00+00:00 https://biolegacyresearch.com/ex-genentechers-denali-scores-1b-alzheimers-deal-with-takeda/ 2018-01-05T00:00:00+00:00 https://biolegacyresearch.com/kala-pharma-sinks-on-mixed-data-from-two-phase-iii-dry-eye-disease-studies/ 2018-01-05T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-relay-therapeutics/ 2018-01-05T00:00:00+00:00